<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Med Chem</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Med Chem</journal-id>
    <journal-id journal-id-type="publisher-id">jm</journal-id>
    <journal-id journal-id-type="coden">jmcmar</journal-id>
    <journal-title-group>
      <journal-title>Journal of Medicinal Chemistry</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0022-2623</issn>
    <issn pub-type="epub">1520-4804</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10388294</article-id>
    <article-id pub-id-type="pmid">37449459</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jmedchem.3c00481</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DruMAP: A Novel
Drug Metabolism and Pharmacokinetics
Analysis Platform</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3612-4294</contrib-id>
        <name>
          <surname>Kawashima</surname>
          <given-names>Hitoshi</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath2">
        <name>
          <surname>Watanabe</surname>
          <given-names>Reiko</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8780-6346</contrib-id>
        <name>
          <surname>Esaki</surname>
          <given-names>Tsuyoshi</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3260-9630</contrib-id>
        <name>
          <surname>Kuroda</surname>
          <given-names>Masataka</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7721-0642</contrib-id>
        <name>
          <surname>Nagao</surname>
          <given-names>Chioko</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Natsume-Kitatani</surname>
          <given-names>Yayoi</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Ohashi</surname>
          <given-names>Rikiya</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <name>
          <surname>Komura</surname>
          <given-names>Hiroshi</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath9">
        <name>
          <surname>Mizuguchi</surname>
          <given-names>Kenji</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Artificial
Intelligence Center for Health and Biomedical Research, <institution>National Institutes of Biomedical Innovation, Health
and Nutrition</institution>, Settsu, Osaka 566-0002, <country>Japan</country></aff>
      <aff id="aff2"><label>‡</label>Laboratory
for Computational Biology, Institute for Protein Research, <institution>Osaka University</institution>, Suita, Osaka 565-0871, <country>Japan</country></aff>
      <aff id="aff3"><label>§</label>Data
Science and AI Innovation Research Promotion Center, <institution>Shiga University</institution>, Hikone, Shiga 522-8522, <country>Japan</country></aff>
      <aff id="aff4"><label>∥</label>Discovery
Technology Laboratories, <institution>Mitsubishi Tanabe
Pharma Corporation</institution>, Yokohama, Kanagawa 227-0033, <country>Japan</country></aff>
      <aff id="aff5"><label>⊥</label>Institute
of Advanced Medical Sciences, <institution>Tokushima
University</institution>, Tokushima, Tokushima 770-8503, <country>Japan</country></aff>
      <aff id="aff6"><label>#</label>University
Research Administration Center, <institution>Osaka Metropolitan
University</institution>, Osaka, Osaka 545-0051, <country>Japan</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>hkawashi@nibiohn.go.jp</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>reiko-watanabe@protein.osaka-u.ac.jp</email>.</corresp>
      <corresp id="cor3"><label>*</label>Email: <email>kenji@protein.osaka-u.ac.jp</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>14</day>
      <month>07</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>27</day>
      <month>07</month>
      <year>2023</year>
    </pub-date>
    <volume>66</volume>
    <issue>14</issue>
    <fpage>9697</fpage>
    <lpage>9709</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>03</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0007" id="ab-tgr1"/>
      </p>
      <p>We developed a novel drug metabolism and pharmacokinetics
(DMPK)
analysis platform named DruMAP. This platform consists of a database
for DMPK parameters and programs that can predict many DMPK parameters
based on the chemical structure of a compound. The DruMAP database
includes curated DMPK parameters from public sources and in-house
experimental data obtained under standardized conditions; it also
stores predicted DMPK parameters produced by our prediction programs.
Users can predict several DMPK parameters simultaneously for novel
compounds not found in the database. Furthermore, the highly flexible
search system enables users to search for compounds as they desire.
The current version of DruMAP comprises more than 30,000 chemical
compounds, about 40,000 activity values (collected from public databases
and in-house data), and about 600,000 predicted values. Our platform
provides a simple tool for searching and predicting DMPK parameters
and is expected to contribute to the acceleration of new drug development.
DruMAP can be freely accessed at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://drumap.nibiohn.go.jp/">https://drumap.nibiohn.go.jp/</uri>.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Japan Agency for Medical Research and Development</institution>
            <institution-id institution-id-type="doi">10.13039/100009619</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>JP15nk0101101</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Japan Agency for Medical Research and Development</institution>
            <institution-id institution-id-type="doi">10.13039/100009619</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>JP20nk0101111</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>jm3c00481</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>jm3c00481</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>It is well known that the development
of new drugs is time-consuming
and expensive.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> There are many issues to
be solved in new drug development. Among them, drug metabolism and
pharmacokinetics (DMPK) and toxicity issues have often interrupted
drug development in the past. Therefore, pharmaceutical companies
have incorporated assessments of these parameters in the early stages
of drug discovery. However, the discovery of new drug targets becomes
more difficult with each passing year because the number of factors
to be evaluated in toxicology has increased as the safety assignment
has evolved, and a full range of drugs that can be developed relatively
effortlessly have already been developed. Consequently, a high level
of expertise is required to discover a new target, and thus, the role
of academia or startup companies with special technologies is increasing.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> However, it is nearly impossible for academia
or startup companies to conduct large-scale pharmacokinetic and toxicological
screening studies for new drug candidates, as pharmaceutical companies
do. To bridge this gap, a computer-based prediction system is considered
to be useful.</p>
    <p>There are several tools and software programs
that can predict
physicochemical, pharmacokinetic, and toxicological parameters simultaneously
from a chemical structure, such as SwissADME,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> OCHEM,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> pkCSM,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> ADMETlab,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and the vNN web server.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Most of these programs were trained using publicly
available data. In building prediction models, the quality and quantity
of the training dataset are critical. DMPK data are widely available
in public chemical databases, such as ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and PubChem.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> However, these data were
collected under different experimental conditions, leading to different
experimental values. Moreover, although the ChEMBL database has standard
values and standard unit fields, these units are not necessarily standardized
across experiments. For example, in the case of hepatic intrinsic
clearance, some ChEMBL data are incorrectly assigned between hepatic
clearance and hepatic intrinsic clearance. Curating these data requires
equation-based conversion in addition to unit conversion (details
are described in the <xref rid="sec4" ref-type="other">Experimental Section</xref>).
Such curation can improve the prediction accuracy of machine learning,
as previously shown.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup></p>
    <p>In this study,
we developed DruMAP, a <underline>Dru</underline>g <underline>M</underline>etabolism and pharmacokinetics <underline>A</underline>nalysis <underline>P</underline>latform. DruMAP not
only provides new prediction results for DMPK parameters for a compound
but is also an integrated database that stores data used to train
our prediction programs and results from them. As the number of data
points has a great influence on the performance of a prediction program,
we newly acquired experimental data to increase the amount of data.
In addition, we applied extensive manual curation to public data before
integrating them into our database. We compiled the prediction programs
that we had previously developed and published for predicting parameters
such as the fraction unbound in plasma (<italic>f</italic><sub>u,p</sub>),<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> fraction unbound in brain homogenate (<italic>f</italic><sub>u,brain</sub>),<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> unbound brain-to-plasma
concentration ratio (<italic>K</italic><sub>p,uu,brain</sub>),<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> hepatic intrinsic clearance in liver microsome
(<italic>CL</italic><sub>int</sub>),<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> fraction
absorbed (<italic>F</italic><sub>a</sub>),<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and fraction of drug excreted unchanged in urine (<italic>f</italic><sub>e</sub>),<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> as well as several newly
developed models. DruMAP provides a freely accessible computational
resource for a comprehensive database of DMPK parameters and programs
to predict DMPK parameters based on the chemical structure of a compound.</p>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>Overview of the DruMAP System</title>
      <p>DruMAP consists of a
database of DMPK parameters of drug-like small molecules and programs
to predict many DMPK parameters, as shown in the Table of Contents
Graphic. The top page of the DruMAP web application has “Compound
search,” “Activity search,” and “New prediction”
buttons that allow the users to select the function that they wish
to use (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).
The database part includes organic compounds with molecular weights
less than 2000 Da in their salt-free form. It includes many DMPK parameters
collected and curated from public sources, obtained by in-house experiments,
or predicted by DruMAP prediction programs, as shown in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. The data are stored in a PostgreSQL
database. Users can search for compounds by their structure, name,
and identifiers of commonly used chemical databases. They can also
search for compounds by filtering activities and properties or by
creating more complex query conditions. Compound reports show all
the activity data for the selected compound. The prediction part provides
prediction programs for many DMPK parameters, as shown in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. The users can predict
those parameters from their structure.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Top page of the DruMAP
web application.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0002" id="gr1" position="float"/>
      </fig>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Total Number of Data Stored in DruMAP
for Each Parameter</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center"> </th>
              <th style="border:none;" align="center">parameter name</th>
              <th style="border:none;" align="center">parameter type</th>
              <th style="border:none;" align="center">unit</th>
              <th style="border:none;" align="center">species</th>
              <th style="border:none;" align="center">in-house data</th>
              <th style="border:none;" align="center">curated public data</th>
              <th style="border:none;" align="center">common
technical document</th>
              <th style="border:none;" align="center">interview form</th>
              <th style="border:none;" align="center">predicted data</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">physico-chemical parameters</td>
              <td style="border:none;" align="left">solubility (pH 7.4)</td>
              <td style="border:none;" align="left">
                <italic>D-Sol</italic>
                <sub>7.4</sub>
              </td>
              <td style="border:none;" align="left">μg/mL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left">367</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">solubility (pH 1.2)</td>
              <td style="border:none;" align="left">
                <italic>D-Sol</italic>
                <sub>1.2</sub>
              </td>
              <td style="border:none;" align="left">μg/mL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">distribution
coefficient (pH 7.4)</td>
              <td style="border:none;" align="left">log <italic>D</italic><sub>7.4</sub></td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">120</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>in vitro</italic> parameters</td>
              <td style="border:none;" align="left">fraction unbound in plasma</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">441</td>
              <td style="border:none;" align="left">2319</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">55,010</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">422</td>
              <td style="border:none;" align="left">120</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">55,010</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction unbound in brain homogenate</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">443</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">mammal</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">253</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">blood-to-plasma concentration
ratio</td>
              <td style="border:none;" align="left">
                <italic>R</italic>
                <sub>b</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">213</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">hepatic intrinsic clearance in the liver microsome</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>int</sub>
              </td>
              <td style="border:none;" align="left">μL/min/mg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">166</td>
              <td style="border:none;" align="left">5230</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">54,977</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">μL/min/mg</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">167</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP1A2</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP2C9</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP2D6</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP3A4</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">site
metabolized by CYP1A2</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">10,018</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">site
metabolized by CYP3A4</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">10,644</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">permeability
coefficient (Caco-2)</td>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app</sub>
              </td>
              <td style="border:none;" align="left">nm/s</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">4408</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">permeability coefficient (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app</sub>
              </td>
              <td style="border:none;" align="left">nm/s</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">925</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,503</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">115</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">pig</td>
              <td style="border:none;" align="left">1042</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">P-gp efflux ratio (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>ER</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">463</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">58</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">pig</td>
              <td style="border:none;" align="left">521</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">P-gp net efflux ratio (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>NER</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">446</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">57</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>in vivo</italic> parameters</td>
              <td style="border:none;" align="left">drug concentration
in plasma</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">1335</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">16</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">drug concentration in tissues</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">1535</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">1141</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">initial drug concentration in plasma</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
                <sub>0</sub>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">49</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">peak drug concentration</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
                <sub>max</sub>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">366</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">elimination half-life of a drug</td>
              <td style="border:none;" align="left">
                <italic>T</italic>
                <sub>1/2</sub>
              </td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">415</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">65</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">time
to reach peak drug concentration</td>
              <td style="border:none;" align="left">
                <italic>T</italic>
                <sub>max</sub>
              </td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">366</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">area under the drug concentration–time curve</td>
              <td style="border:none;" align="left">AUC</td>
              <td style="border:none;" align="left">ng·h/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">830</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">70</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">mean residence time of a
drug in plasma</td>
              <td style="border:none;" align="left">MRT</td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">135</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">brain-to-plasma concentration
ratio</td>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">100</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">unbound brain-to-plasma concentration ratio</td>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,uu,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">volume of distribution</td>
              <td style="border:none;" align="left">
                <italic>V</italic>
                <sub>d</sub>
              </td>
              <td style="border:none;" align="left">L/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">102</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">39</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">apparent volume of distribution at oral
administration</td>
              <td style="border:none;" align="left">
                <italic>V</italic>
                <sub>d</sub>
                <italic>/F</italic>
              </td>
              <td style="border:none;" align="left">L/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">197</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">96</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">clearance</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
              </td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">78</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">39</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">apparent
clearance at oral administration</td>
              <td style="border:none;" align="left"><italic>CL</italic>/<italic>F</italic></td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">133</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">96</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">renal clearance</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>r</sub>
              </td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">401</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">35</td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">bioavailability</td>
              <td style="border:none;" align="left">
                <italic>F</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">243</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">35</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">32</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">33</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction absorbed</td>
              <td style="border:none;" align="left">
                <italic>F</italic>
                <sub>a</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">945</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction excreted
in urine</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>e</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">343</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">excretion type in urine</td>
              <td style="border:none;" align="left">
                <italic>CR type</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
          </tbody>
        </table>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center"> </th>
              <th style="border:none;" align="center">parameter name</th>
              <th style="border:none;" align="center">parameter
type</th>
              <th style="border:none;" align="center">unit</th>
              <th style="border:none;" align="center">species</th>
              <th style="border:none;" align="center">data provided by accompanying
projects</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">toxicity</td>
              <td style="border:none;" align="left">binding to hERG channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">9114</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding to Cav<sub>1.2</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">204</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding to Kv<sub>1.5</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">686</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding
to Nav<sub>1.5</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">1321</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">link to hepatotoxicity database DILI-cSEARCH</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human/rat</td>
              <td style="border:none;" align="left">620</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>List of the Prediction Models Implemented
in DruMAP</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">parameter</th>
              <th style="border:none;" align="center">organism/cell/molecule</th>
              <th style="border:none;" align="center">type</th>
              <th style="border:none;" align="center">output</th>
              <th style="border:none;" align="center">accuracy</th>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center">descriptor</th>
              <th style="border:none;" align="center">ref</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left"><italic>Sol</italic>(7.4).class</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;10 μg/mL), high (&gt;10 μg/mL)</td>
              <td style="border:none;" align="left">accuracy: 0.811,
kappa: 0.628</td>
              <td style="border:none;" align="left">L-SVM<xref rid="t2fn1" ref-type="table-fn">a</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>u,p</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0.001–0.05), medium (0.05–0.2), high (0.2–1.0)</td>
              <td style="border:none;" align="left">accuracy: 0.676, true positive
rate in low class: 0.826</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref11">11</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"><italic>R</italic><sup>2</sup> = 0.691</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>u,p</sub>.class</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0.001–0.05), medium (0.05–0.2), high (0.2–1.0)</td>
              <td style="border:none;" align="left">kappa: 0.484</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">MSE = 1.70, <italic>R</italic><sup>2</sup> = 0.51</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,brain</sub>
              </td>
              <td style="border:none;" align="left">mammal</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">MSE = 1.48, <italic>R</italic><sup>2</sup> = 0.58</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>CL</italic><sub>int</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">stable (&lt;20 μL/min/mg), moderate (20–300 μL/min/mg), unstable (&gt;300 μL/min/mg)</td>
              <td style="border:none;" align="left">accuracy: 0.771, kappa:
0.588</td>
              <td style="border:none;" align="left">R-SVM<xref rid="t2fn4" ref-type="table-fn">d</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref10">10</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>int</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">accuracy: 0.788</td>
              <td style="border:none;" align="left">LGBM<xref rid="t2fn5" ref-type="table-fn">e</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CYP.probability</td>
              <td style="border:none;" align="left">human
CYP1A2</td>
              <td style="border:none;" align="left">probability</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">accuracy: 0.617</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, RDKit</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP2C9</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy:
0.600</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP2D6</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy: 0.712</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP3A4</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy: 0.825</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CYP.site</td>
              <td style="border:none;" align="left">human CYP1A2</td>
              <td style="border:none;" align="left">site</td>
              <td style="border:none;" align="left">site</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref34">34</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP3A4</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref35">35</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>P</italic><sub>app(AtoB)</sub>.class</td>
              <td style="border:none;" align="left">human Caco-2</td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;100 nm/s), high (&gt; 100 nm/s)</td>
              <td style="border:none;" align="left">accuracy: 0.810, kappa: 0.601</td>
              <td style="border:none;" align="left">R-SVM<xref rid="t2fn4" ref-type="table-fn">d</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app(AtoB)</sub>
              </td>
              <td style="border:none;" align="left">human P-gp overexpressing LLC-PK1</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"><italic>R</italic><sup>2</sup> = 0.687</td>
              <td style="border:none;" align="left">linear stacking (LGBMe, XGBoost, Catboost, RF<xref rid="t2fn2" ref-type="table-fn">b</xref>, NN<xref rid="t2fn6" ref-type="table-fn">f</xref>)</td>
              <td style="border:none;" align="left">CDK, Mordred, jCompoundMapper,
RDKit</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>P-gp</italic><italic>NER</italic>.class</td>
              <td style="border:none;" align="left">human P-gp</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (&lt;1.4), medium (1.4–9.5), high
(&gt;9.5)</td>
              <td style="border:none;" align="left">kappa = 0.58</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left">Mordred,
jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>F</italic><sub>a</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0–0.2), medium (0.2–0.7), high (0.7–1.0)</td>
              <td style="border:none;" align="left">accuracy: 0.836, kappa: 0.560</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,brain</sub>
              </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">calculation</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,uu,brain</sub>
              </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">calculation</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>r</sub>
              </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">in higher range of (more
than 0.0612 L/h/kg), 70.5% of samples
were fell in within 2-fold error</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref>, PLS<xref rid="t2fn7" ref-type="table-fn">g</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>e</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;0.3), medium-high (&gt;0.3)</td>
              <td style="border:none;" align="left">kappa: 0.49,
balanced accuracy: 0.74</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>CR_type</italic>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">reabsorption, secretion, intermediate</td>
              <td style="border:none;" align="left">kappa: 0.32, balanced accuracy: 0.70, 0.58 and 0.68 in reabsorption,
intermediate and secretion, respectively</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t2fn1">
            <label>a</label>
            <p>L-SVM, linear support vector machine.</p>
          </fn>
          <fn id="t2fn2">
            <label>b</label>
            <p>RF, random forest.</p>
          </fn>
          <fn id="t2fn3">
            <label>c</label>
            <p>GB, gradient boosting.</p>
          </fn>
          <fn id="t2fn4">
            <label>d</label>
            <p>R-SVM, radial support vector machine.</p>
          </fn>
          <fn id="t2fn5">
            <label>e</label>
            <p>LGBM, light gradient boosting
machine.</p>
          </fn>
          <fn id="t2fn6">
            <label>f</label>
            <p>NN, neural network.</p>
          </fn>
          <fn id="t2fn7">
            <label>g</label>
            <p>PLS, partial least square.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="sec2.2">
      <title>Data Integration</title>
      <p>A unique feature of DruMAP is that
it provides a curated database, based on which the offered predictive
models were built. Furthermore, the database, containing data from
multiple public sources including ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and drug approval-related documents, has been supplemented with
data obtained by in-house experiments, both <italic>in vitro</italic> and <italic>in vivo</italic> (see the <xref rid="sec4" ref-type="other">Experimental
Section</xref> for details). We assign unique identifiers to all entries
in DruMAP, where stereochemically related compounds and compounds
with different salts are grouped together and assigned identifiers
that reflect those relationships (see the <xref rid="sec4" ref-type="other">Experimental
Section</xref> for the identifier naming rules). The entries are cross-referenced
to popular databases, such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG
Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> but because of the grouping as mentioned above, the mapping
is not one-to-one, and DruMAP offers richer information on related
chemical structures than other databases. Each entry can also be accessed <italic>via</italic> TargetMine,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> an integrated
data warehouse for drug discovery.</p>
    </sec>
    <sec id="sec2.3">
      <title>Compound Search</title>
      <p>The compound search function (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) provides various
query forms to search the DruMAP database using structure, activity,
property, compound name, or identifiers. For structure search, JSME
Molecular Editor<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> was used to draw chemical
compounds in DruMAP (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Users can perform either a substructure or a similarity
search. The similarity score of a compound is calculated based on
the Tanimoto similarity coefficient of morgan fingerprints, using
the RDKit<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> morganbv_fp function. For an
activity or property search, users can create search expressions,
as will be described in the “Activity search” section
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). For a
name or identifier search, users can search for compounds by a list
of names, a list of identifiers (such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> identifiers in addition to DruMAP identifiers),
or a list of chemical structural descriptions (InChI or InChIKey,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> SMILES,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> and MOL
or SDF files). Users can combine the above conditions by selecting
INTERSECT, UNION, or EXCEPT. The search results are shown as a list
of compounds with a link to the compound report view.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Compound search, which
allows the user to select compounds based
on structure (A), activity, property, compound name, or identifiers
(B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0003" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.4">
      <title>Activity Search</title>
      <p>Activity search (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) provides an interface to search the DruMAP
database based on DruMAP identifiers, assay type, activity values,
or category of organisms, tissue, target molecule, route, dose, time,
parameter, or source. Users can edit conditional expressions to construct
a complex query. The search results are presented in a manner similar
to the compound search result view, but with activity data instead
of compound data.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Activity search, which provides an interface for searching
the
DruMAP database based on the activity range, predicted category class,
or other data fields.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0004" id="gr3" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.5">
      <title>Compound Report</title>
      <p>Compound report (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>) can be accessed from the search results
of compound search or activity search. It shows all data related to
an individual compound. There are 11 subsections in this view: “Top,”
“Structures,” “Chemical spaces,” “Related
compounds,” “External links,” “Physicochemical
properties,” “Activities (physicochemical),”
“Activities (<italic>in vitr</italic>o),” “Activities
(<italic>in vivo</italic>),” “Activities (prediction),”
and “Toxicity.” The “Top” section of this
view has basic information, including compound names, synonyms, molecular
formulae, salt, molecular weights, and the exact mass of the most
abundant atomic species. The “Structures” section provides
a text format of the compound structure, such as SMILES, InChI, or
InChIKey. The “Chemical space” section shows the position
of the designated compound in the collection of compounds registered
in DruMAP. Users can change the <italic>x</italic>-axis or <italic>y</italic>-axis parameters as per their preference. The “Related
compound” section provides links to the compounds with different
salts or stereoisomers. The “External links” section
provides links to external databases, such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> The “Physicochemical properties”
section collects basic physicochemical properties calculated using
RDKit.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The three “Activities”
sections provide curated public or experimentally obtained data for
each category. By default, the activity data for related compounds
are displayed with the specified compound and can be turned off by
clearing the “include related compounds” check box.
If there are time-dependent concentration data in plasma or tissues,
a line graph showing the time-dependent curve is displayed along with
the table. Each line can be turned on or off by checking or clearing
the check boxes in the table. The “Activities (prediction)”
section provides data predicted by our prediction programs for a maximum
of 23 DMPK parameters. Finally, the “Toxicity” section
has links, if any, to cardiotoxicity<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> or
hepatotoxicity<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> data generated in other
related projects (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.id3inst.org/">https://www.id3inst.org/</uri>).</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Compound report, which provides all data relevant to the compound
searched <italic>via</italic> the compound or activity search functions.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.6">
      <title>New Prediction</title>
      <p>New prediction (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A) provides an interface to predict DMPK
parameters solely from user-provided structural information of compounds
in SDF (Structural Data File) or the SMILES format. To date, we have
constructed 23 prediction models and are working on several other
models. Details of the methods used to construct these models have
been published<sup><xref ref-type="bibr" rid="ref10">10</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup> or will be published elsewhere. <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> lists the models that we prepared. These
prediction models have been integrated to DruMAP, and the users can
predict DMPK parameters for up to 30 compounds simultaneously. For
the prediction of <italic>K</italic><sub>p,brain</sub> and <italic>K</italic><sub>p,uu,brain</sub>, log <italic>P</italic> and
acidic/basic p<italic>K</italic><sub>a</sub> values are required in
addition to the compound structure information. The user may enter
any known values of log <italic>P</italic> and acidic/basic p<italic>K</italic><sub>a</sub> in the appeared input field; if the input
field is left blank, the log <italic>P</italic> value calculated using
RDKit and the p<italic>K</italic><sub>a</sub> value calculated using
ChemAxon Calculator Plugins (Chemaxon, Budapest, Hungary) will be
substituted to the prediction of <italic>K</italic><sub>p,brain</sub> and <italic>K</italic><sub>p,uu,brain</sub>. The prediction results
are presented in a tabular format (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B). The chemical space of the compounds by
principal component analysis (PCA) with descriptors that are used
for the construction of each prediction model is displayed along with
the position of the compound to be predicted (currently available
only for <italic>f</italic><sub>u,p</sub>, <italic>f</italic><sub>u,brain</sub>, <italic>f</italic><sub>e</sub>, and the type of the
clearance ratio, <italic>CR_type</italic>).</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>New prediction, which
provides an interface for predicting DMPK
parameters from user-provided compounds (A). Prediction results are
presented in a tabular format with a chemical space graph when available
(B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0006" id="gr5" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.7">
      <title>Case Study 1</title>
      <p>One of the most common uses of DruMAP
is to comprehensively view DMPK data of a compound, including DruMAP-predicted
data. In what follows, we explain how to use DruMAP, using propranolol
hydrochloride as an example.</p>
      <p>First, click on “Compound
search” on the top page of the DruMAP web application. Then,
a form for entering search conditions will be displayed. Select “Name”
and input “propranolol” (or only “propr”)
in the input box, then click on the “Search” button.
Click on “propranolol hydrochloride” from the search
results listed.</p>
      <p>On the “Compound report” page,
one can view all the
information about propranolol hydrochloride or its desalted form,
propranolol, as described in the “Compound report” section.
At the top, one can see the compound’s DruMAP identifier (DIJ0000210800-01)
and examine its basic properties. In the “Chemical space”
section, one can select the <italic>x</italic>-axis to be “Freebase
molecular weight” and the <italic>y</italic>-axis to be “PSA”
(polar surface area), which reveals that this compound (shown in red)
is situated in the bottom left part of the chemical space spanned
by all DruMAP entries.</p>
      <p>Furthermore, users can view all activity
data obtained through <italic>in vitro</italic> experiments in “Activities
(<italic>in vitro</italic>)” section. For example, the human
fraction unbound in the
plasma (<italic>f</italic><sub>u,p</sub>) value is 0.169 in the NIBIOHN
source (our in-house experiments) and 0.100 in the ChEMBL source.
Furthermore, users can view activity data obtained through <italic>in vivo</italic> experiments in the “Activities (<italic>in
vivo</italic>)” section. For example, one can view time-dependent
plasma concentrations of the drug and the pharmacokinetic parameters
calculated from them, such as elimination half-life in plasma (<italic>T</italic><sub>1/2</sub>) or the apparent volume of distribution
at a steady state (<italic>Vd</italic><sub>ss</sub><italic>/F</italic>) after intravenous injection (<italic>i.v.</italic>) of the drug
into male Sprague–Dawley (SD) rats in no. 1 of the table. As
time-dependent concentration data in plasma and tissues are available
for this compound, a line graph showing the time-dependent curve is
displayed along with the table. By clearing the check box at the top
of the activity table (just left of “no.”) and checking
nos. 1 and 4, one can visually check the time-dependent concentrations
in plasma and brain, which reveals that this compound is well translocated
into the brain.</p>
      <p>Finally, one can view the data predicted by
our prediction programs
in the “Activities (prediction)” section. For example, <italic>f</italic><sub>u,p</sub> and <italic>CL</italic><sub>int</sub> values
in humans are 0.140 and 15.1 μL/min/mg, respectively.</p>
    </sec>
    <sec id="sec2.8">
      <title>Case Study 2</title>
      <p>Another useful use of DruMAP is to select
the appropriate compounds that meet several conditions. Here, as an
example, we explain how to select compounds that are expected to have
metabolic stability and excellent transferability to the central nervous
system.</p>
      <p>First, click on “Compound search” on the
top page of DruMAP. Then, select “Activity” from the
list box, and click on the “Set conditions” button.
A pop-up window similar to the activity search will appear, and use
the “Add rule” button to create a search expression
as shown in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B. The “Add group” button allows the user to define
multiple compound sets with any desired properties. Multiple conditions
can be set and combined to filter compounds according to the user’s
preferred conditions. Click on the “Apply” button to
set the search conditions, and the search conditions will be displayed
under the “Set conditions” button. Finally, compounds
can be filtered according to the setting after the “Search”
button is clicked on.</p>
      <p>The following is an example of searching
for compounds that are
metabolically stable, non-substrates for P-gp (P-glycoprotein), and
migratable to the brain. First, click on “Add group”
three times and set three empty compound sets with selecting “intersect”.
Then, set conditions in activity for each of the three compound sets
with the following conditions. Conditions 1 are Source = “DruMAP
prediction” AND organism = “human” AND parameter
= “<italic>CL</italic>int.class” AND Activity value
(Class) = “Stable”, conditions 2 are Source = “DruMAP
prediction” AND organism = “human” AND target
molecule = “P-gp” AND parameter = “NER.class”
AND Activity value (Class) = “Low”, conditions 3 are
Source = “DruMAP prediction” AND organism = “rat”
AND tissue = “brain” AND parameter = “Kp,uu”
AND activity value ≥0.5. This search expression will return
compounds, for which human <italic>CL</italic><sub>int</sub>.class
is “Stable,” human <italic>P-gp NER</italic>.class is
“Low” and rat <italic>K</italic><sub>p,uu,brain</sub> ≥ 0.5. In DruMAP, human <italic>CL</italic><sub>int</sub> is classified into “Stable” (&lt;20 μL/min/mg),
“Moderate” (20–300 μL/min/mg), and “Unstable”
(&gt;300 μL/min/mg), and <italic>P-gp NER</italic>.class is
classified
into “Low” (1–1.4), “Medium” (1.4–9.8),
and “High” (&gt;9.8). <italic>K</italic><sub>p,uu,brain</sub> represents the ratio of the concentration of unbound compound in
the brain and plasma, and, as human <italic>K</italic><sub>p,uu,brain</sub> data are unavailable, we used rat data instead. Finally, by clicking
on the “Search” button, the compounds in all conditions
1–3 can be obtained.</p>
      <p>The search results will be shown
below the search expression. The
current version of DruMAP returns 2840 candidate compounds. The user
can further filter the results by adding a property or structure search.
For example, selecting the “substructure” option in
the structure search and drawing a substructure results in less compounds
remaining. The user can examine each of those compounds by clicking
on the corresponding row.</p>
      <p>The user can thus create a list of
compounds that meet the search
conditions and export the DruMAP identifier list by clicking on “Download
ID list”, then perform an activity search by uploading the
list of DruMAP identifiers. In this way, it can be possible to find
a group of chemical compounds with suitable pharmacokinetic properties.
Alternatively, the user can save a list of compounds that meet the
search conditions and use it to create a compound library for a high-throughput
screening of new drugs.</p>
    </sec>
    <sec id="sec2.9">
      <title>Case Study 3</title>
      <p>The next case aimed to design a compound
with appropriate properties based on a compound not found in DruMAP.
Suppose you have compound A whose SMILES structure is “O=c1c(F)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.”
You can identify similar compounds <italic>via</italic> the following
steps: select “Structure” and “Similarity”
in the “Compound search,” and click on “Draw
structure.” Then, click on the blue up-down triangles at the
top of the chemical input box, click on “Paste MOL or SDF or
SMILES,” paste the SMILES structure of compound A in the input
box, click on “Accept,” and click on “Apply.”
You can also input the SMILES structure in the “Draw structure”
box. Then, set the threshold to 0.5, and click on “Search.”
The search result field shows four compounds: kaempferol, luteolin,
morin, and quercetin. You can view their prediction values by clicking
on each compound. For <italic>K</italic><sub>p,uu,brain</sub>, the
values are 0.172, 0.237, 0.042, and 0.059, respectively. Then, you
can alter certain residues to design new compounds. After saving the
structures as SDF or SMILES, you can load them on the “New
prediction” page. After placing a check mark in the “<italic>K</italic><sub>p,brain</sub><italic>K</italic><sub>p,uu,brain</sub>” line, press “Calculate” to display the prediction
results (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B).
This will identify compounds with higher (“O=c1c(Cl)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,”
0.598) and lower <italic>K</italic><sub>p,uu,brain</sub> values (“O=C1c2c(O)cc(O)cc2OC(c2ccc(O)c(O)c2O)C1O,”
0.022) among the similar compounds than the starting compound (0.219).</p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion and Conclusions</title>
    <p>We have released a platform
named DruMAP that consists of a database
and an associated prediction system. The database contains curated
public and in-house data used for the construction of prediction models
for various pharmacokinetic parameters from absorption to secretion,
such as <italic>D-Sol</italic>, <italic>f</italic><sub>u,p</sub>, <italic>f</italic><sub>u,brain</sub>, <italic>CL</italic><sub>int</sub>,
permeability coefficient for Caco-2 cells, <italic>CL</italic><sub>r</sub>, <italic>F</italic><sub>a</sub>, and <italic>f</italic><sub>e</sub>. In addition, it contains prediction results for more than
27,000 compounds, pre-calculated using our prediction models. The
user can search the database by keywords, compound identifiers, structural
descriptions such as InChI or SMILES, and parameter values. Furthermore,
DruMAP can predict DMPK parameters for user-input compounds using
our prediction programs. This platform is useful for early DMPK studies
and candidate compound selection to accelerate novel drug development.</p>
    <p>There are several tools and software programs dealing with pharmacokinetic
prediction. Among them, SwissADME,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> pkCSM,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> and ADMETlab<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> have
a similar concept as that of DruMAP. They can also predict many physicochemical
and pharmacokinetic parameters from a chemical structure. DruMAP can
predict parameter values such as <italic>CL</italic><sub>int</sub>, <italic>CL</italic><sub>r</sub>, <italic>f</italic><sub>e</sub>, and <italic>K</italic><sub>p,uu,brain</sub> that are not available
in SwissADME, pkCSM, and ADMETlab. We have not generated prediction
models for CYP inhibition; however, we plan to include them in a future
version. Moreover, DruMAP stores results precalculated by our prediction
models for many compounds, and a very flexible filtering system is
available, allowing users to define filters for compounds fit for
their purposes, as described in Case Study 2. We plan to extend the
compound data in DruMAP to commercially available compounds and all
organic compounds in the ChEMBL database with molecular weights less
than 2000 Da in their salt-free form. Then, DruMAP could be used as
a pre-screening tool for better pharmacological profiles from tens
of millions of library compounds.</p>
    <p>The most important factor
to create accurate prediction models
is to collect high-quality experimental data as much as possible.
To this end, we have established a consortium with seven pharmaceutical
companies and obtained chemical descriptors and experimental data
for several pharmacokinetic parameters from these companies,<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> although these data are proprietary to the companies and we cannot
provide them in DruMAP. Another approach to increase experimental
data is to collect data from documents on new drug applications, such
as Common Technical Document (CTD), package inserts, or Interview
Form (IF), which is a supplementary document of the package insert
of a launched drug specifically in Japan. These documents are publicly
available from the Pharmaceuticals and Medical Devices Agency (PMDA).
However, these documents are not well structured, and some of them
are not in text format but in image format; thus, it is nearly impossible
to use them as-is. We started digitizing these data and incorporating
them into the DruMAP database. At present, we have stored only a limited
number of DMPK data from CTD and IF, but we are planning to comprehensively
collect these data. Afterwards, we will create more models for other
DMPK parameters.</p>
    <p>In conclusion, DruMAP enables searching experimental
and predicted
DMPK data and predicting DMPK parameters for novel compounds. We continue
to develop the DruMAP system to improve its functions. We hope that
DruMAP can contribute to the acceleration of new drug discovery.</p>
  </sec>
  <sec id="sec4">
    <title>Experimental Section</title>
    <sec id="sec4.1">
      <title>Chemical Compounds Registered in the DruMAP Database</title>
      <p>DruMAP includes organic compounds with molecular weights less than
2000 Da in their salt-free form. All chemicals in KEGG Drug<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> that do not fall into this category, such as
combination drugs, inorganic compounds, and macromolecular compounds,
were excluded. DruMAP distinguishes compounds with different salts
while ignoring the water of crystallization and solvents such as ethanol
and acetone. In addition, compounds that can be interconverted in
aqueous solution were summarized under one compound identifier.</p>
      <p>We have given compounds our own identifier, drumap_id. It consists
of a three-letter prefix (“DIJ”) and a ten-digit number
followed by a two-digit number that indicates stereoisomers, a hyphen
(“-”), and a two-digit number. We defined the first
11 characters as the compound core identifier. The last two-digit
number is used to discriminate salt differences, and “00”
is used for chemicals without salt. The two-digit number immediately
before the hyphen is used to discriminate between enantiomers and
diastereomers. These four digits do not affect the calculation of
physicochemical properties. Furthermore, they do not affect the calculation
of descriptors because we used two dimensional descriptors for the
development of the prediction models. The current version of DruMAP
(1.5) contains 30,971 compounds, of which 27,500 are salt-free and
3471 contain salts. On ignoring salts and stereoisomerism, the number
of compounds is 25,622.</p>
    </sec>
    <sec id="sec4.2">
      <title>Chemicals Used in <italic>In Vitro</italic> and <italic>In Vivo</italic> Experiments</title>
      <p>Chemicals used in the experiments were commercially
available compounds with guaranteed purity (&gt;95%) and purchased
from
Abcam (Cambridge, UK), AdooQ Bioscience (Irvine, CA, USA), Advanced
ChemBlocks (Burlingame, CA, USA), Alomone Labs (Jerusalem, Israel),
AN PharmaTech (Shanghai, China), Ark Pharm (Arlington Heights, IL,
USA), AvaChem Scientific (San Antonio, TX, USA), Bachem (Bubendorf,
Switzerland), Carbosynth (Berkshire, UK), Cayman Chemical (Ann Arbor,
MI, USA), Chem-Impex International (Wood Dale, IL, USA), ChemScene
(Monmouth Junction, NJ, USA), Combi-Blocks (San Diego, CA, USA), Corning
(New York, NY, USA), EDQM Council of Europe (Strasbourg, France),
Enamine (Monmouth Junction, NJ, USA), eNovation Chemicals (Green Brook,
NJ, USA), Fujifilm Wako Pure Chemical (Osaka, Japan), LC Laboratories
(Woburn, MA, USA), Life Chemicals (Burlington, Canada), LKT Laboratories
(St. Paul, MN, USA), Maybridge (Leicestershire, UK), MedChem Express
(Princeton, NJ, USA), Pharmeks (Moscow, Russia), Santa Cruz Biotechnology
(Dallas, TX, USA), Selleck Chemicals (Houston, TX, USA), Shanghai
BioChemPartner (Wuhan, China), Sigma-Aldrich (St. Louis, MO, USA),
Specs (Zoetermeer, The Netherlands), Target Molecule (Wellesley Hills,
MA, USA), TLC Pharmaceutical Standards (Aurora, Canada), Tocris Bioscience
(Bristol, UK), Tokyo Chemical Industry (Tokyo, Japan), Toronto Research
Chemicals (Toronto, Canada), The United States Pharmacopeial Convention
(Rockville, MD, USA), and Vitas M Chemical (Causeway Bay, Hong Kong).</p>
    </sec>
    <sec id="sec4.3">
      <title><italic>In Vitro</italic> Experimental Data Collection</title>
      <p>Solubilities at pH 7.4 and pH 1.2 (<italic>D-Sol</italic><sub>7.4</sub> and <italic>D-Sol</italic><sub>1.2</sub>) at 25 °C were measured
using the dried-DMSO method.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> We also
measured the distribution coefficient at pH 7.4 (log <italic>D</italic><sub>7.4</sub>) at 25 °C. These parameters are known to affect
the absorption and renal excretion of drugs. The fraction unbound
in plasma (<italic>f</italic><sub>u,p</sub>) determines drug efficacy
because only the unbound drug is capable of interacting with target
proteins and is able to diffuse between plasma and tissues. The <italic>f</italic><sub>u,p</sub> values were calculated from the drug concentrations
in plasma and in phosphate-buffered saline (PBS) after incubation
of the drug with human or rat plasma, separated from PBS using a dialysis
membrane. The fraction unbound in brain homogenate (<italic>f</italic><sub>u,brain</sub>) provides an estimate of the amount of unbound
drug in the central nervous system. The <italic>f</italic><sub>u,brain</sub> value was calculated from the drug concentration in brain homogenate
and in PBS after incubation of the drug with rat brain homogenate,
separated from PBS using a dialysis membrane. The <italic>CL</italic><sub>int</sub> values were calculated from the slope of the plot
of log-transformed drug concentration <italic>versus</italic> time
after incubation with human or rat liver microsomes (Sekisui XenoTech,
Kansas City, KS, USA). All experiments were carried out at Sumika
Chemical Analysis Service (SCAS, Osaka, Japan).</p>
    </sec>
    <sec id="sec4.4">
      <title><italic>In Vivo</italic> Experimental Data Collection</title>
      <p>We measured drug concentrations in plasma and tissues (brain, cerebrospinal
fluid, heart, lungs, liver, kidneys, and muscle) after intravenous
(<italic>i.v.</italic>) or per oral (<italic>p.o.</italic>) administration
of a drug in Crl/CD (SD) male rats (Jackson Laboratory Japan, Yokohama,
Japan). The following pharmacokinetic parameters were calculated using
Phoenix WinNonlin version 8.1 (Certara, Princeton, NJ, USA): initial
concentration (<italic>C</italic><sub>0</sub>), peak concentration
(<italic>C</italic><sub>max</sub>), elimination half-life (<italic>T</italic><sub>1/2</sub>), time to reach maximum concentration (<italic>T</italic><sub>max</sub>), area under the concentration–time
curve from zero to the last sampling time (AUC<sub>0–<italic>t</italic></sub>), area under the concentration–time curve
from zero to infinity (AUC<sub>inf</sub>), apparent volume of distribution
at steady state (<italic>V</italic><sub>dss</sub>), total clearance
(<italic>CL</italic>), mean residence time from zero to infinity (MRT<sub>inf</sub>) for <italic>i.v.</italic> administration and <italic>C</italic><sub>max</sub>, <italic>T</italic><sub>1/2</sub>, <italic>T</italic><sub>max</sub>, AUC<sub>0–<italic>t</italic></sub>, AUC<sub>inf</sub>, apparent volume of distribution during the terminal phase
(<italic>V</italic><sub>z</sub><italic>/F</italic>), apparent total
clearance (<italic>CL</italic>/<italic>F</italic>), and MRT<sub>inf</sub> for <italic>p.o.</italic> administration. Tissue plasma partition
coefficients (<italic>K</italic><sub>p,tissue</sub>) were calculated
for the seven tissues by dividing each tissue concentration by the
plasma concentration at a steady state. When both <italic>i.v.</italic> and <italic>p.o.</italic> data were measured for a compound, bioavailability
(<italic>F</italic>) was calculated using <xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>, where <italic>D</italic> is the administration
dose.<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_m001" position="anchor"/><label>1</label></disp-formula></p>
      <p>We also measured drug concentrations
in plasma, brain, and cerebrospinal fluid after <italic>i.v.</italic> or <italic>p.o.</italic> drug administration in <italic>Abcb1a</italic> (<italic>Mdr1a</italic>) and <italic>Abcb1b</italic> (<italic>Mdr1b</italic>) knock-out SD-(<italic>Abcb1a-Abcb1b</italic>)<sup><italic>em1Sage</italic></sup> male rats (Horizon Discovery, Boyertown, PA, USA). A cocktail
of five compounds was administered. All experiments using rats were
carried out at Shin Nippon Biomedical Laboratories (SNBL, Tokyo, Japan)
under the approval of the Institutional Animal Care and Use Committee
of NIBIOHN and SNBL. All experiments using SD-(<italic>Abcb1a-Abcb1b</italic>)<sup><italic>em1Sage</italic></sup> rats were carried out under
the approval of the Recombinant Gene Experiment Safety Committee of
SNBL.</p>
    </sec>
    <sec id="sec4.5">
      <title>Public Data Collection</title>
      <p>Public data were extracted from
ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> version 30, Interview Forms downloaded
from PMDA in Japan (which included supplementary documents of package
inserts of launched drugs), a summary of CTDs downloaded from PMDA,
and from articles describing DMPK data.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref31">31</xref></sup></p>
    </sec>
    <sec id="sec4.6">
      <title>Data Curation</title>
      <p>All data were manually curated. The curation
process included standardization of units; however, other important
factors must also be considered. For example, we collected data of
fractions unbound in plasma, but ChEMBL also contains data of fractions
that are bound. In this case, the fraction must be subtracted from
1 to convert the data to fraction-unbound form. Moreover, hepatic
intrinsic clearance is usually expressed as the rate of metabolism
per 1 mg of hepatic microsomal protein. A similar parameter, hepatic
clearance, is usually expressed as the rate of metabolism per 1 g
of liver or per 1 kg of body weight. To obtain hepatic intrinsic clearance
values, hepatic clearance should be converted using liver weight per
kg of body mass and hepatic microsome weight per g of liver. A key
issue is that hepatic clearance and hepatic intrinsic clearance are
sometimes not correctly annotated in the ChEMBL database, leading
to inappropriate conversion. Details on the curation process have
been described in the respective articles on the prediction models.<sup><xref ref-type="bibr" rid="ref10">10</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup></p>
    </sec>
    <sec id="sec4.7">
      <title>Data Processing</title>
      <p>To use the activity value data for
machine learning, it is necessary to set one activity value per compound
for each parameter. We defined the representative activity value as
follows. We assigned data categories to all the activity data, and
if there was only one activity data for one parameter and one compound
ignoring salts, the data were assigned as data category 1. If there
were two or more data for one parameter and one compound, we assigned
representative activity values as follows. We assigned data category
4 to ambiguous data, such as those with the word “about”
or those that were expressed as a range of activities appearing mostly
in Interview Forms, and data category 3 to other data. If there was
only one category 3 data, the data were assigned as category 2, and
if there were two or more category 3 data, the geometric mean value
and geometric standard deviation were calculated to assign them as
category 2 data. If there were no category 3 data, category 4 data
were used as category 2 data. All category 1 and category 2 data were
used as representative activity data in the DruMAP system.</p>
    </sec>
    <sec id="sec4.8">
      <title>Structure Data</title>
      <p>We stored chemical structures as the
SMILES format standardized using the ChEMBL structure pipeline.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> The SMILES was converted to the InChI<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> format to summarize tautomers using RDKit.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> InChI descriptions can summarize most of the
tautomers. Tautomers that could not be summarized using InChI descriptions
were managed using a different tautomer identifier for the same compound.
To calculate prediction values, we needed the chemical descriptors
shown in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> for
each parameter. The SMILES of a compound was converted into MOL format
using Open Babel 3.1.0<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> to calculate these
descriptors. The MolDraw2DSVG function of RDKit was used for drawing
the chemical structure.</p>
    </sec>
    <sec id="sec4.9">
      <title>Database Schema</title>
      <p>The curated public data, our experimental
and predicted data, and chemical data were stored in a PostgreSQL
database. A schema of the DruMAP database is presented in Supplementary <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.3c00481/suppl_file/jm3c00481_si_001.pdf">Figure S1</ext-link>.</p>
    </sec>
    <sec id="sec4.10">
      <title>Compound Search in DruMAP</title>
      <p>Partial matching of query
strings with the ILIKE operator (case-insensitive) in PostgreSQL was
used for chemical name searches. An RDKit PostgreSQL Cartridge was
used for substructure and similarity searches of the compounds.</p>
    </sec>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00481?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00481</ext-link>.<list id="silist" list-type="simple"><list-item><p>PostgreSQL schema of the DruMAP database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.3c00481/suppl_file/jm3c00481_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_si_001.pdf">
        <caption>
          <p>jm3c00481_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes2">
    <title>Author Contributions</title>
    <p>H.Ka. and
R.W. contributed equally. K.M. designed and supervised the entire
study, and all authors planned the study; H.Ka. designed the database
schema, entered data into the DruMAP database, and wrote the manuscript;
R.W. collected the public data, constructed the prediction models,
and wrote the manuscript; T.E. and M.K. collected the public data
and constructed the prediction models; R.O. and H.Ko. provided guidance
on the pharmacokinetics section. All authors read and approved the
manuscript.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d14e2255-autogenerated">
    <p>The authors declare
no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This study was supported by the Japan Agency for
Medical Research and Development (AMED) under grant numbers JP15nk0101101
and JP20nk0101111. We thank D. Sato (Lifematics, Tokyo, Japan) for
the development of the web interface, J. Ohori and H. Koga (Fujitsu,
Tokyo, Japan) for the development of the prediction programs for CYP
metabolism, Y. Hori and K. Kamiya (SyntheticGestalt, Tokyo, Japan)
for the development of the <italic>CL</italic><sub>int</sub> regression
model, and Y. Yanagihashi (Lifematics) for the development of the
LLC-PK1 Papp model. We also thank L. P. Tripathi for the naming of
DruMAP. We would like to thank Editage for English language editing.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>AMED</term>
        <def>
          <p>Japan
Agency for Medical Research
and Development</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p>area under the drug concentration–time curve</p>
        </def>
      </def-item>
      <def-item>
        <term>CTD</term>
        <def>
          <p>common technical document</p>
        </def>
      </def-item>
      <def-item>
        <term>CYP</term>
        <def>
          <p>cytochrome P-450</p>
        </def>
      </def-item>
      <def-item>
        <term>DMPK</term>
        <def>
          <p>drug metabolism
and pharmacokinetics</p>
        </def>
      </def-item>
      <def-item>
        <term>IF</term>
        <def>
          <p>interview form</p>
        </def>
      </def-item>
      <def-item>
        <term>i.v.</term>
        <def>
          <p>intravenous</p>
        </def>
      </def-item>
      <def-item>
        <term>NER</term>
        <def>
          <p>net efflux ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>PBS</term>
        <def>
          <p>phosphate-buffered saline</p>
        </def>
      </def-item>
      <def-item>
        <term>P-gp</term>
        <def>
          <p>P-glycoprotein</p>
        </def>
      </def-item>
      <def-item>
        <term>PMDA</term>
        <def>
          <p>Pharmaceuticals and Medical Devices Agency</p>
        </def>
      </def-item>
      <def-item>
        <term>p.o.</term>
        <def>
          <p>per oral</p>
        </def>
      </def-item>
      <def-item>
        <term>SD</term>
        <def>
          <p>Sprague–Dawley</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Chan</surname><given-names>H. S.</given-names></name>; <name><surname>Shan</surname><given-names>H.</given-names></name>; <name><surname>Dahoun</surname><given-names>T.</given-names></name>; <name><surname>Vogel</surname><given-names>H.</given-names></name>; <name><surname>Yuan</surname><given-names>S.</given-names></name><article-title>Advancing
drug discovery via artificial intelligence</article-title>. <source>Trends Pharmacol. Sci.</source><year>2019</year>, <volume>40</volume>, <fpage>592</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2019.06.004</pub-id>.<pub-id pub-id-type="pmid">31320117</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Shamas-Din</surname><given-names>A.</given-names></name>; <name><surname>Schimmer</surname><given-names>A. D.</given-names></name><article-title>Drug discovery in
academia</article-title>. <source>Exp.
Hematol.</source><year>2015</year>, <volume>43</volume>, <fpage>713</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2015.02.007</pub-id>.<pub-id pub-id-type="pmid">25912018</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Daina</surname><given-names>A.</given-names></name>; <name><surname>Michielin</surname><given-names>O.</given-names></name>; <name><surname>Zoete</surname><given-names>V.</given-names></name><article-title>SwissADME: a free web tool to evaluate
pharmacokinetics, drug-likeness and medicinal chemistry friendliness
of small molecules</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume>, <fpage>42717</fpage><pub-id pub-id-type="doi">10.1038/srep42717</pub-id>.<pub-id pub-id-type="pmid">28256516</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Sushko</surname><given-names>I.</given-names></name>; <name><surname>Novotarskyi</surname><given-names>S.</given-names></name>; <name><surname>Körner</surname><given-names>R.</given-names></name>; <name><surname>Pandey</surname><given-names>A. K.</given-names></name>; <name><surname>Rupp</surname><given-names>M.</given-names></name>; <name><surname>Teetz</surname><given-names>W.</given-names></name>; <name><surname>Brandmaier</surname><given-names>S.</given-names></name>; <name><surname>Abdelaziz</surname><given-names>A.</given-names></name>; <name><surname>Prokopenko</surname><given-names>V. V.</given-names></name>; <name><surname>Tanchuk</surname><given-names>V. Y.</given-names></name>; <name><surname>Todeschini</surname><given-names>R.</given-names></name>; <name><surname>Varnek</surname><given-names>A.</given-names></name>; <name><surname>Marcou</surname><given-names>G.</given-names></name>; <name><surname>Ertl</surname><given-names>P.</given-names></name>; <name><surname>Potemkin</surname><given-names>V.</given-names></name>; <name><surname>Grishina</surname><given-names>M.</given-names></name>; <name><surname>Gasteiger</surname><given-names>J.</given-names></name>; <name><surname>Schwab</surname><given-names>C.</given-names></name>; <name><surname>Baskin</surname><given-names>I. I.</given-names></name>; <name><surname>Palyulin</surname><given-names>V. A.</given-names></name>; <name><surname>Radchenko</surname><given-names>E. V.</given-names></name>; <name><surname>Welsh</surname><given-names>W. J.</given-names></name>; <name><surname>Kholodovych</surname><given-names>V.</given-names></name>; <name><surname>Chekmarev</surname><given-names>D.</given-names></name>; <name><surname>Cherkasov</surname><given-names>A.</given-names></name>; <name><surname>Aires-de-Sousa</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>Q. Y.</given-names></name>; <name><surname>Bender</surname><given-names>A.</given-names></name>; <name><surname>Nigsch</surname><given-names>F.</given-names></name>; <name><surname>Patiny</surname><given-names>L.</given-names></name>; <name><surname>Williams</surname><given-names>A.</given-names></name>; <name><surname>Tkachenko</surname><given-names>V.</given-names></name>; <name><surname>Tetko</surname><given-names>I. V.</given-names></name><article-title>Online chemical
modeling environment (OCHEM): web platform for data storage, model
development and publishing of chemical information</article-title>. <source>J. Comput. Aided Mol. Des.</source><year>2011</year>, <volume>25</volume>, <fpage>533</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-011-9440-2</pub-id>.<pub-id pub-id-type="pmid">21660515</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Pires</surname><given-names>D. E. V.</given-names></name>; <name><surname>Blundell</surname><given-names>T. L.</given-names></name>; <name><surname>Ascher</surname><given-names>D. B.</given-names></name><article-title>pkCSM: predicting
small-molecule
pharmacokinetic and toxicity properties using graph-based signatures</article-title>. <source>J. Med. Chem.</source><year>2015</year>, <volume>58</volume>, <fpage>4066</fpage>–<lpage>4072</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00104</pub-id>.<pub-id pub-id-type="pmid">25860834</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Xiong</surname><given-names>G.</given-names></name>; <name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>J.</given-names></name>; <name><surname>Fu</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Hsieh</surname><given-names>C.</given-names></name>; <name><surname>Yin</surname><given-names>M.</given-names></name>; <name><surname>Zeng</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>C.</given-names></name>; <name><surname>Lu</surname><given-names>A.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Hou</surname><given-names>T.</given-names></name>; <name><surname>Cao</surname><given-names>D.</given-names></name><article-title>ADMETlab 2.0: an integrated online platform for accurate
and comprehensive predictions of ADMET properties</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>W5</fpage>–<lpage>W14</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab255</pub-id>.<pub-id pub-id-type="pmid">33893803</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Schyman</surname><given-names>P.</given-names></name>; <name><surname>Liu</surname><given-names>R.</given-names></name>; <name><surname>Desai</surname><given-names>V.</given-names></name>; <name><surname>Wallqvist</surname><given-names>A.</given-names></name><article-title>vNN web server for ADMET predictions</article-title>. <source>Front. Pharmacol.</source><year>2017</year>, <volume>8</volume>, <fpage>889</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00889</pub-id>.<pub-id pub-id-type="pmid">29255418</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Mendez</surname><given-names>D.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Chambers</surname><given-names>J.</given-names></name>; <name><surname>De Veij</surname><given-names>M.</given-names></name>; <name><surname>Félix</surname><given-names>E.</given-names></name>; <name><surname>Magariños</surname><given-names>M. P.</given-names></name>; <name><surname>Mosquera</surname><given-names>J. F.</given-names></name>; <name><surname>Mutowo</surname><given-names>P.</given-names></name>; <name><surname>Nowotka</surname><given-names>M.</given-names></name>; <name><surname>Gordillo-Marañón</surname><given-names>M.</given-names></name>; <name><surname>Hunter</surname><given-names>F.</given-names></name>; <name><surname>Junco</surname><given-names>L.</given-names></name>; <name><surname>Mugumbate</surname><given-names>G.</given-names></name>; <name><surname>Rodriguez-Lopez</surname><given-names>M.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Bosc</surname><given-names>N.</given-names></name>; <name><surname>Radoux</surname><given-names>C. J.</given-names></name>; <name><surname>Segura-Cabrera</surname><given-names>A.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Leach</surname><given-names>A. R.</given-names></name><article-title>ChEMBL:
towards
direct deposition of bioassay data</article-title>. <source>Nucleic
Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>D930</fpage>–<lpage>D940</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id>.<pub-id pub-id-type="pmid">30398643</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name>; <name><surname>Cheng</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Gindulyte</surname><given-names>A.</given-names></name>; <name><surname>Shoemaker</surname><given-names>B. A.</given-names></name>; <name><surname>Thiessen</surname><given-names>P. A.</given-names></name>; <name><surname>He</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name><article-title>PubChem BioAssay:
2017 update</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>D955</fpage>–<lpage>D963</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1118</pub-id>.<pub-id pub-id-type="pmid">27899599</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Data curation
can improve the prediction
accuracy of metabolic intrinsic clearance</article-title>. <source>Mol.
Inf.</source><year>2019</year>, <volume>38</volume>, <elocation-id>e1800086</elocation-id><pub-id pub-id-type="doi">10.1002/minf.201800086</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Predicting
fraction unbound in human plasma from chemical structure: improved
accuracy in the low value ranges</article-title>. <source>Mol. Pharm.</source><year>2018</year>, <volume>15</volume>, <fpage>5302</fpage>–<lpage>5311</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00785</pub-id>.<pub-id pub-id-type="pmid">30259749</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Development
of an <italic>In Silico</italic> Prediction Model for P-glycoprotein
Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction
of Brain Penetration</article-title>. <source>J. Med. Chem.</source><year>2021</year>, <volume>64</volume>, <fpage>2725</fpage>–<lpage>2738</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c02011</pub-id>.<pub-id pub-id-type="pmid">33619967</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Computational
model to predict the fraction of unbound drug in the brain</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>3251</fpage>–<lpage>3261</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00180</pub-id>.<pub-id pub-id-type="pmid">31260629</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Constructing
an in silico three-class predictor of human intestinal absorption
with Caco-2 permeability and dried-DMSO solubility</article-title>. <source>J. Pharm. Sci.</source><year>2019</year>, <volume>108</volume>, <fpage>3630</fpage>–<lpage>3639</lpage>. <pub-id pub-id-type="doi">10.1016/j.xphs.2019.07.014</pub-id>.<pub-id pub-id-type="pmid">31351866</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Development
of an in silico prediction system of human renal excretion and clearance
from chemical structure information incorporating fraction unbound
in plasma as a descriptor</article-title>. <source>Sci. Rep.</source><year>2019</year>, <volume>9</volume>, <fpage>18782</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-55325-1</pub-id>.<pub-id pub-id-type="pmid">31827176</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Kanehisa</surname><given-names>M.</given-names></name>; <name><surname>Furumichi</surname><given-names>M.</given-names></name>; <name><surname>Tanabe</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>Y.</given-names></name>; <name><surname>Morishima</surname><given-names>K.</given-names></name><article-title>KEGG: new
perspectives on genomes, pathways, diseases and drugs</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>D353</fpage>–<lpage>D361</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1092</pub-id>.<pub-id pub-id-type="pmid">27899662</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Wishart</surname><given-names>D. S.</given-names></name>; <name><surname>Feunang</surname><given-names>Y. D.</given-names></name>; <name><surname>Guo</surname><given-names>A. C.</given-names></name>; <name><surname>Lo</surname><given-names>E. J.</given-names></name>; <name><surname>Marcu</surname><given-names>A.</given-names></name>; <name><surname>Grant</surname><given-names>J. R.</given-names></name>; <name><surname>Sajed</surname><given-names>T.</given-names></name>; <name><surname>Johnson</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Sayeeda</surname><given-names>Z.</given-names></name>; <name><surname>Assempour</surname><given-names>N.</given-names></name>; <name><surname>Iynkkaran</surname><given-names>I.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Maciejewski</surname><given-names>A.</given-names></name>; <name><surname>Gale</surname><given-names>N.</given-names></name>; <name><surname>Wilson</surname><given-names>A.</given-names></name>; <name><surname>Chin</surname><given-names>L.</given-names></name>; <name><surname>Cummings</surname><given-names>R.</given-names></name>; <name><surname>Le</surname><given-names>D.</given-names></name>; <name><surname>Pon</surname><given-names>A.</given-names></name>; <name><surname>Knox</surname><given-names>C.</given-names></name>; <name><surname>Wilson</surname><given-names>M.</given-names></name><article-title>DrugBank 5.0: a major update to the DrugBank database
for 2018</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>D1074</fpage>–<lpage>D1082</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>.<pub-id pub-id-type="pmid">29126136</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Chen</surname><given-names>Y. A.</given-names></name>; <name><surname>Tripathi</surname><given-names>L. P.</given-names></name>; <name><surname>Fujiwara</surname><given-names>T.</given-names></name>; <name><surname>Kameyama</surname><given-names>T.</given-names></name>; <name><surname>Itoh</surname><given-names>M. N.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>The TargetMine data warehouse: enhancement and updates</article-title>. <source>Front. Genet.</source><year>2019</year>, <volume>10</volume>, <fpage>934</fpage><pub-id pub-id-type="doi">10.3389/fgene.2019.00934</pub-id>.<pub-id pub-id-type="pmid">31649722</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Bienfait</surname><given-names>B.</given-names></name>; <name><surname>Ertl</surname><given-names>P.</given-names></name><article-title>JSME: a free molecule
editor in JavaScript</article-title>. <source>J. Cheminf.</source><year>2013</year>, <volume>5</volume>, <fpage>24</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-5-24</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="weblink" id="cit20"><article-title>RDKit: Open-source cheminformatics software</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rdkit.org/">http://www.rdkit.org/</uri> (accessed
Mar 8, 2023).</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Heller</surname><given-names>S. R.</given-names></name>; <name><surname>McNaught</surname><given-names>A.</given-names></name>; <name><surname>Pletnev</surname><given-names>I.</given-names></name>; <name><surname>Stein</surname><given-names>S.</given-names></name>; <name><surname>Tchekhovskoi</surname><given-names>D.</given-names></name><article-title>InChI, the
IUPAC international chemical identifier</article-title>. <source>J.
Cheminf.</source><year>2015</year>, <volume>7</volume>, <fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0068-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Weininger</surname><given-names>D.</given-names></name>; <name><surname>Weininger</surname><given-names>A.</given-names></name>; <name><surname>Weininger</surname><given-names>J. L.</given-names></name><article-title>SMILES 2. Algorithm for generation
of unique SMILES notation</article-title>. <source>J. Chem. Inf. Comput.
Sci.</source><year>1989</year>, <volume>29</volume>, <fpage>97</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1021/ci00062a008</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Yuki</surname><given-names>H.</given-names></name>; <name><surname>Ogura</surname><given-names>K.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name><article-title>Construction of an
integrated database for hERG blocking small molecules</article-title>. <source>PLoS One</source><year>2018</year>, <volume>13</volume>, <elocation-id>e0199348</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0199348</pub-id>.<pub-id pub-id-type="pmid">29979714</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="weblink" id="cit24"><article-title>DILI-cSEARCH</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dili-csearch.nibiohn.go.jp/en">https://dili-csearch.nibiohn.go.jp/en</uri> (accessed Mar 8, 2023).</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>A public-private
partnership to enrich the development of in silico predictive models
for pharmacokinetic and cardiotoxic properties</article-title>. <source>Drug Discov. Today</source><year>2021</year>, <volume>26</volume>, <fpage>1275</fpage>–<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2021.01.024</pub-id>.<pub-id pub-id-type="pmid">33516857</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Utilizing public and private sector
data to build better
machine learning models for the prediction of pharmacokinetic parameters</article-title>. <source>Drug Discov. Today</source><year>2022</year>, <volume>27</volume>, <fpage>103339</fpage><pub-id pub-id-type="doi">10.1016/j.drudis.2022.103339</pub-id>.<pub-id pub-id-type="pmid">35973660</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Varma</surname><given-names>M. V. S.</given-names></name>; <name><surname>Feng</surname><given-names>B.</given-names></name>; <name><surname>Obach</surname><given-names>R. S.</given-names></name>; <name><surname>Troutman</surname><given-names>M. D.</given-names></name>; <name><surname>Chupka</surname><given-names>J.</given-names></name>; <name><surname>Miller</surname><given-names>H. R.</given-names></name>; <name><surname>El-Kattan</surname><given-names>A.</given-names></name><article-title>Physicochemical
determinants of human
renal clearance</article-title>. <source>J. Med. Chem.</source><year>2009</year>, <volume>52</volume>, <fpage>4844</fpage>–<lpage>4852</lpage>. <pub-id pub-id-type="doi">10.1021/jm900403j</pub-id>.<pub-id pub-id-type="pmid">19445515</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Varma</surname><given-names>M. V. S.</given-names></name>; <name><surname>Obach</surname><given-names>R. S.</given-names></name>; <name><surname>Rotter</surname><given-names>C.</given-names></name>; <name><surname>Miller</surname><given-names>H. R.</given-names></name>; <name><surname>Chang</surname><given-names>G.</given-names></name>; <name><surname>Steyn</surname><given-names>S. J.</given-names></name>; <name><surname>El-Kattan</surname><given-names>A.</given-names></name>; <name><surname>Troutman</surname><given-names>M. D.</given-names></name><article-title>Physicochemical
space for optimum oral bioavailability: contribution of human intestinal
absorption and first pass elimination</article-title>. <source>J. Med.
Chem.</source><year>2010</year>, <volume>53</volume>, <fpage>1098</fpage>–<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1021/jm901371v</pub-id>.<pub-id pub-id-type="pmid">20070106</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Ito</surname><given-names>S.</given-names></name>; <name><surname>Ando</surname><given-names>H.</given-names></name>; <name><surname>Ose</surname><given-names>A.</given-names></name>; <name><surname>Kitamura</surname><given-names>Y.</given-names></name>; <name><surname>Ando</surname><given-names>T.</given-names></name>; <name><surname>Kusuhara</surname><given-names>H.</given-names></name>; <name><surname>Sugiyama</surname><given-names>Y.</given-names></name><article-title>Relationship
between the urinary
excretion mechanisms of drugs and their physicochemical properties</article-title>. <source>J. Pharm. Sci.</source><year>2013</year>, <volume>102</volume>, <fpage>3294</fpage>–<lpage>3301</lpage>. <pub-id pub-id-type="doi">10.1002/jps.23599</pub-id>.<pub-id pub-id-type="pmid">23712676</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Benet</surname><given-names>L. Z.</given-names></name>; <name><surname>Broccatelli</surname><given-names>F.</given-names></name>; <name><surname>Oprea</surname><given-names>T. I.</given-names></name><article-title>BDDCS applied to over 900 drugs</article-title>. <source>AAPS J.</source><year>2011</year>, <volume>13</volume>, <fpage>519</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-011-9290-9</pub-id>.<pub-id pub-id-type="pmid">21818695</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Hosey</surname><given-names>C. M.</given-names></name>; <name><surname>Chan</surname><given-names>R.</given-names></name>; <name><surname>Benet</surname><given-names>L. Z.</given-names></name><article-title>BDDCS predictions,
self-correcting
aspects of BDDCS assignments, BDDCS assignment corrections, and classification
for more than 175 additional drugs</article-title>. <source>AAPS J.</source><year>2016</year>, <volume>18</volume>, <fpage>251</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-015-9845-2</pub-id>.<pub-id pub-id-type="pmid">26589308</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Félix</surname><given-names>E.</given-names></name>; <name><surname>Landrum</surname><given-names>G.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Bellis</surname><given-names>L. J.</given-names></name>; <name><surname>De Veij</surname><given-names>M.</given-names></name>; <name><surname>Leach</surname><given-names>A. R.</given-names></name><article-title>An open
source chemical structure curation pipeline using RDKit</article-title>. <source>J. Cheminf.</source><year>2020</year>, <volume>12</volume>, <fpage>51</fpage><pub-id pub-id-type="doi">10.1186/s13321-020-00456-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>O’Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name><article-title>Open Babel:
an open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Yamazoe</surname><given-names>Y.</given-names></name>; <name><surname>Ito</surname><given-names>K.</given-names></name>; <name><surname>Yamamura</surname><given-names>Y.</given-names></name>; <name><surname>Iwama</surname><given-names>R.</given-names></name>; <name><surname>Yoshinari</surname><given-names>K.</given-names></name><article-title>Prediction
of regioselectivity and preferred order of metabolisms on CYP1A2-mediated
reactions. Part 1. Focusing on polycyclic arenes and the related chemicals</article-title>. <source>Drug Metab. Pharmacokinet.</source><year>2016</year>, <volume>31</volume>, <fpage>363</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2016.07.005</pub-id>.<pub-id pub-id-type="pmid">27665699</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Yamazoe</surname><given-names>Y.</given-names></name>; <name><surname>Goto</surname><given-names>T.</given-names></name>; <name><surname>Tohkin</surname><given-names>M.</given-names></name><article-title>Reconstitution of CYP3A4
active site
through assembly of ligand interactions as a grid-template: solving
the modes of the metabolism and inhibition</article-title>. <source>Drug Metab. Pharmacokinet.</source><year>2019</year>, <volume>34</volume>, <fpage>113</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2018.10.001</pub-id>.<pub-id pub-id-type="pmid">30639283</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//ACS//DTD ACS Journal DTD v1.02 20061031//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName ACSJournal-v102.dtd?>
<?SourceDTD.Version 1.02?>
<?ConverterInfo.XSLTName acs2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">J Med Chem</journal-id>
    <journal-id journal-id-type="iso-abbrev">J Med Chem</journal-id>
    <journal-id journal-id-type="publisher-id">jm</journal-id>
    <journal-id journal-id-type="coden">jmcmar</journal-id>
    <journal-title-group>
      <journal-title>Journal of Medicinal Chemistry</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">0022-2623</issn>
    <issn pub-type="epub">1520-4804</issn>
    <publisher>
      <publisher-name>American Chemical Society</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10388294</article-id>
    <article-id pub-id-type="pmid">37449459</article-id>
    <article-id pub-id-type="doi">10.1021/acs.jmedchem.3c00481</article-id>
    <article-categories>
      <subj-group>
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>DruMAP: A Novel
Drug Metabolism and Pharmacokinetics
Analysis Platform</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author" corresp="yes" id="ath1">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3612-4294</contrib-id>
        <name>
          <surname>Kawashima</surname>
          <given-names>Hitoshi</given-names>
        </name>
        <xref rid="cor1" ref-type="other">*</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath2">
        <name>
          <surname>Watanabe</surname>
          <given-names>Reiko</given-names>
        </name>
        <xref rid="cor2" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath3">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-8780-6346</contrib-id>
        <name>
          <surname>Esaki</surname>
          <given-names>Tsuyoshi</given-names>
        </name>
        <xref rid="aff3" ref-type="aff">§</xref>
      </contrib>
      <contrib contrib-type="author" id="ath4">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-3260-9630</contrib-id>
        <name>
          <surname>Kuroda</surname>
          <given-names>Masataka</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff4" ref-type="aff">∥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath5">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7721-0642</contrib-id>
        <name>
          <surname>Nagao</surname>
          <given-names>Chioko</given-names>
        </name>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath6">
        <name>
          <surname>Natsume-Kitatani</surname>
          <given-names>Yayoi</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
        <xref rid="aff5" ref-type="aff">⊥</xref>
      </contrib>
      <contrib contrib-type="author" id="ath7">
        <name>
          <surname>Ohashi</surname>
          <given-names>Rikiya</given-names>
        </name>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <contrib contrib-type="author" id="ath8">
        <name>
          <surname>Komura</surname>
          <given-names>Hiroshi</given-names>
        </name>
        <xref rid="aff6" ref-type="aff">#</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes" id="ath9">
        <name>
          <surname>Mizuguchi</surname>
          <given-names>Kenji</given-names>
        </name>
        <xref rid="cor3" ref-type="other">*</xref>
        <xref rid="aff2" ref-type="aff">‡</xref>
        <xref rid="aff1" ref-type="aff">†</xref>
      </contrib>
      <aff id="aff1"><label>†</label>Artificial
Intelligence Center for Health and Biomedical Research, <institution>National Institutes of Biomedical Innovation, Health
and Nutrition</institution>, Settsu, Osaka 566-0002, <country>Japan</country></aff>
      <aff id="aff2"><label>‡</label>Laboratory
for Computational Biology, Institute for Protein Research, <institution>Osaka University</institution>, Suita, Osaka 565-0871, <country>Japan</country></aff>
      <aff id="aff3"><label>§</label>Data
Science and AI Innovation Research Promotion Center, <institution>Shiga University</institution>, Hikone, Shiga 522-8522, <country>Japan</country></aff>
      <aff id="aff4"><label>∥</label>Discovery
Technology Laboratories, <institution>Mitsubishi Tanabe
Pharma Corporation</institution>, Yokohama, Kanagawa 227-0033, <country>Japan</country></aff>
      <aff id="aff5"><label>⊥</label>Institute
of Advanced Medical Sciences, <institution>Tokushima
University</institution>, Tokushima, Tokushima 770-8503, <country>Japan</country></aff>
      <aff id="aff6"><label>#</label>University
Research Administration Center, <institution>Osaka Metropolitan
University</institution>, Osaka, Osaka 545-0051, <country>Japan</country></aff>
    </contrib-group>
    <author-notes>
      <corresp id="cor1"><label>*</label>Email: <email>hkawashi@nibiohn.go.jp</email>.</corresp>
      <corresp id="cor2"><label>*</label>Email: <email>reiko-watanabe@protein.osaka-u.ac.jp</email>.</corresp>
      <corresp id="cor3"><label>*</label>Email: <email>kenji@protein.osaka-u.ac.jp</email>.</corresp>
    </author-notes>
    <pub-date pub-type="epub">
      <day>14</day>
      <month>07</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <day>27</day>
      <month>07</month>
      <year>2023</year>
    </pub-date>
    <volume>66</volume>
    <issue>14</issue>
    <fpage>9697</fpage>
    <lpage>9709</lpage>
    <history>
      <date date-type="received">
        <day>22</day>
        <month>03</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2023 The Authors. Published by American Chemical Society</copyright-statement>
      <copyright-year>2023</copyright-year>
      <copyright-holder>The Authors</copyright-holder>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref>
        <license-p>Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p content-type="toc-graphic">
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0007" id="ab-tgr1"/>
      </p>
      <p>We developed a novel drug metabolism and pharmacokinetics
(DMPK)
analysis platform named DruMAP. This platform consists of a database
for DMPK parameters and programs that can predict many DMPK parameters
based on the chemical structure of a compound. The DruMAP database
includes curated DMPK parameters from public sources and in-house
experimental data obtained under standardized conditions; it also
stores predicted DMPK parameters produced by our prediction programs.
Users can predict several DMPK parameters simultaneously for novel
compounds not found in the database. Furthermore, the highly flexible
search system enables users to search for compounds as they desire.
The current version of DruMAP comprises more than 30,000 chemical
compounds, about 40,000 activity values (collected from public databases
and in-house data), and about 600,000 predicted values. Our platform
provides a simple tool for searching and predicting DMPK parameters
and is expected to contribute to the acceleration of new drug development.
DruMAP can be freely accessed at: <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://drumap.nibiohn.go.jp/">https://drumap.nibiohn.go.jp/</uri>.</p>
    </abstract>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Japan Agency for Medical Research and Development</institution>
            <institution-id institution-id-type="doi">10.13039/100009619</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>JP15nk0101101</award-id>
      </award-group>
    </funding-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution-wrap>
            <institution>Japan Agency for Medical Research and Development</institution>
            <institution-id institution-id-type="doi">10.13039/100009619</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>JP20nk0101111</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>document-id-old-9</meta-name>
        <meta-value>jm3c00481</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>document-id-new-14</meta-name>
        <meta-value>jm3c00481</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>ccc-price</meta-name>
        <meta-value/>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="sec1">
    <title>Introduction</title>
    <p>It is well known that the development
of new drugs is time-consuming
and expensive.<sup><xref ref-type="bibr" rid="ref1">1</xref></sup> There are many issues to
be solved in new drug development. Among them, drug metabolism and
pharmacokinetics (DMPK) and toxicity issues have often interrupted
drug development in the past. Therefore, pharmaceutical companies
have incorporated assessments of these parameters in the early stages
of drug discovery. However, the discovery of new drug targets becomes
more difficult with each passing year because the number of factors
to be evaluated in toxicology has increased as the safety assignment
has evolved, and a full range of drugs that can be developed relatively
effortlessly have already been developed. Consequently, a high level
of expertise is required to discover a new target, and thus, the role
of academia or startup companies with special technologies is increasing.<sup><xref ref-type="bibr" rid="ref2">2</xref></sup> However, it is nearly impossible for academia
or startup companies to conduct large-scale pharmacokinetic and toxicological
screening studies for new drug candidates, as pharmaceutical companies
do. To bridge this gap, a computer-based prediction system is considered
to be useful.</p>
    <p>There are several tools and software programs
that can predict
physicochemical, pharmacokinetic, and toxicological parameters simultaneously
from a chemical structure, such as SwissADME,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> OCHEM,<sup><xref ref-type="bibr" rid="ref4">4</xref></sup> pkCSM,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> ADMETlab,<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> and the vNN web server.<sup><xref ref-type="bibr" rid="ref7">7</xref></sup> Most of these programs were trained using publicly
available data. In building prediction models, the quality and quantity
of the training dataset are critical. DMPK data are widely available
in public chemical databases, such as ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and PubChem.<sup><xref ref-type="bibr" rid="ref9">9</xref></sup> However, these data were
collected under different experimental conditions, leading to different
experimental values. Moreover, although the ChEMBL database has standard
values and standard unit fields, these units are not necessarily standardized
across experiments. For example, in the case of hepatic intrinsic
clearance, some ChEMBL data are incorrectly assigned between hepatic
clearance and hepatic intrinsic clearance. Curating these data requires
equation-based conversion in addition to unit conversion (details
are described in the <xref rid="sec4" ref-type="other">Experimental Section</xref>).
Such curation can improve the prediction accuracy of machine learning,
as previously shown.<sup><xref ref-type="bibr" rid="ref10">10</xref></sup></p>
    <p>In this study,
we developed DruMAP, a <underline>Dru</underline>g <underline>M</underline>etabolism and pharmacokinetics <underline>A</underline>nalysis <underline>P</underline>latform. DruMAP not
only provides new prediction results for DMPK parameters for a compound
but is also an integrated database that stores data used to train
our prediction programs and results from them. As the number of data
points has a great influence on the performance of a prediction program,
we newly acquired experimental data to increase the amount of data.
In addition, we applied extensive manual curation to public data before
integrating them into our database. We compiled the prediction programs
that we had previously developed and published for predicting parameters
such as the fraction unbound in plasma (<italic>f</italic><sub>u,p</sub>),<sup><xref ref-type="bibr" rid="ref11">11</xref>,<xref ref-type="bibr" rid="ref12">12</xref></sup> fraction unbound in brain homogenate (<italic>f</italic><sub>u,brain</sub>),<sup><xref ref-type="bibr" rid="ref12">12</xref>,<xref ref-type="bibr" rid="ref13">13</xref></sup> unbound brain-to-plasma
concentration ratio (<italic>K</italic><sub>p,uu,brain</sub>),<sup><xref ref-type="bibr" rid="ref12">12</xref></sup> hepatic intrinsic clearance in liver microsome
(<italic>CL</italic><sub>int</sub>),<sup><xref ref-type="bibr" rid="ref10">10</xref></sup> fraction
absorbed (<italic>F</italic><sub>a</sub>),<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> and fraction of drug excreted unchanged in urine (<italic>f</italic><sub>e</sub>),<sup><xref ref-type="bibr" rid="ref15">15</xref></sup> as well as several newly
developed models. DruMAP provides a freely accessible computational
resource for a comprehensive database of DMPK parameters and programs
to predict DMPK parameters based on the chemical structure of a compound.</p>
  </sec>
  <sec id="sec2">
    <title>Results</title>
    <sec id="sec2.1">
      <title>Overview of the DruMAP System</title>
      <p>DruMAP consists of a
database of DMPK parameters of drug-like small molecules and programs
to predict many DMPK parameters, as shown in the Table of Contents
Graphic. The top page of the DruMAP web application has “Compound
search,” “Activity search,” and “New prediction”
buttons that allow the users to select the function that they wish
to use (<xref rid="fig1" ref-type="fig">Figure <xref rid="fig1" ref-type="fig">1</xref></xref>).
The database part includes organic compounds with molecular weights
less than 2000 Da in their salt-free form. It includes many DMPK parameters
collected and curated from public sources, obtained by in-house experiments,
or predicted by DruMAP prediction programs, as shown in <xref rid="tbl1" ref-type="other">Table <xref rid="tbl1" ref-type="other">1</xref></xref>. The data are stored in a PostgreSQL
database. Users can search for compounds by their structure, name,
and identifiers of commonly used chemical databases. They can also
search for compounds by filtering activities and properties or by
creating more complex query conditions. Compound reports show all
the activity data for the selected compound. The prediction part provides
prediction programs for many DMPK parameters, as shown in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref>. The users can predict
those parameters from their structure.</p>
      <fig id="fig1" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Top page of the DruMAP
web application.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0002" id="gr1" position="float"/>
      </fig>
      <table-wrap id="tbl1" position="float">
        <label>Table 1</label>
        <caption>
          <title>Total Number of Data Stored in DruMAP
for Each Parameter</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center"> </th>
              <th style="border:none;" align="center">parameter name</th>
              <th style="border:none;" align="center">parameter type</th>
              <th style="border:none;" align="center">unit</th>
              <th style="border:none;" align="center">species</th>
              <th style="border:none;" align="center">in-house data</th>
              <th style="border:none;" align="center">curated public data</th>
              <th style="border:none;" align="center">common
technical document</th>
              <th style="border:none;" align="center">interview form</th>
              <th style="border:none;" align="center">predicted data</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">physico-chemical parameters</td>
              <td style="border:none;" align="left">solubility (pH 7.4)</td>
              <td style="border:none;" align="left">
                <italic>D-Sol</italic>
                <sub>7.4</sub>
              </td>
              <td style="border:none;" align="left">μg/mL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left">367</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">solubility (pH 1.2)</td>
              <td style="border:none;" align="left">
                <italic>D-Sol</italic>
                <sub>1.2</sub>
              </td>
              <td style="border:none;" align="left">μg/mL</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">distribution
coefficient (pH 7.4)</td>
              <td style="border:none;" align="left">log <italic>D</italic><sub>7.4</sub></td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">120</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>in vitro</italic> parameters</td>
              <td style="border:none;" align="left">fraction unbound in plasma</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">441</td>
              <td style="border:none;" align="left">2319</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">55,010</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">422</td>
              <td style="border:none;" align="left">120</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">55,010</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction unbound in brain homogenate</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">443</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">mammal</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">253</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">blood-to-plasma concentration
ratio</td>
              <td style="border:none;" align="left">
                <italic>R</italic>
                <sub>b</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">213</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">163</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">hepatic intrinsic clearance in the liver microsome</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>int</sub>
              </td>
              <td style="border:none;" align="left">μL/min/mg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">166</td>
              <td style="border:none;" align="left">5230</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">54,977</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">μL/min/mg</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">167</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP1A2</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP2C9</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP2D6</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">probability
metabolized by CYP3A4</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">site
metabolized by CYP1A2</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">10,018</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">site
metabolized by CYP3A4</td>
              <td style="border:none;" align="left">CYP</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">10,644</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">permeability
coefficient (Caco-2)</td>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app</sub>
              </td>
              <td style="border:none;" align="left">nm/s</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">4408</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">permeability coefficient (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app</sub>
              </td>
              <td style="border:none;" align="left">nm/s</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">925</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,503</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">115</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">pig</td>
              <td style="border:none;" align="left">1042</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">P-gp efflux ratio (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>ER</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">463</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">58</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">pig</td>
              <td style="border:none;" align="left">521</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">P-gp net efflux ratio (LLC-PK1)</td>
              <td style="border:none;" align="left">
                <italic>NER</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">446</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">57</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>in vivo</italic> parameters</td>
              <td style="border:none;" align="left">drug concentration
in plasma</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">1335</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">16</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">drug concentration in tissues</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">1535</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">1141</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">initial drug concentration in plasma</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
                <sub>0</sub>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">49</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">peak drug concentration</td>
              <td style="border:none;" align="left">
                <italic>C</italic>
                <sub>max</sub>
              </td>
              <td style="border:none;" align="left">ng/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">366</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">elimination half-life of a drug</td>
              <td style="border:none;" align="left">
                <italic>T</italic>
                <sub>1/2</sub>
              </td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">415</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">65</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">time
to reach peak drug concentration</td>
              <td style="border:none;" align="left">
                <italic>T</italic>
                <sub>max</sub>
              </td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">366</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">area under the drug concentration–time curve</td>
              <td style="border:none;" align="left">AUC</td>
              <td style="border:none;" align="left">ng·h/mL</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">830</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">70</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">mean residence time of a
drug in plasma</td>
              <td style="border:none;" align="left">MRT</td>
              <td style="border:none;" align="left">h</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">135</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">brain-to-plasma concentration
ratio</td>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">100</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">unbound brain-to-plasma concentration ratio</td>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,uu,brain</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">volume of distribution</td>
              <td style="border:none;" align="left">
                <italic>V</italic>
                <sub>d</sub>
              </td>
              <td style="border:none;" align="left">L/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">102</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">39</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">5</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">12</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">apparent volume of distribution at oral
administration</td>
              <td style="border:none;" align="left">
                <italic>V</italic>
                <sub>d</sub>
                <italic>/F</italic>
              </td>
              <td style="border:none;" align="left">L/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">197</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">96</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">clearance</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
              </td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">78</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">39</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">3</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">4</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">apparent
clearance at oral administration</td>
              <td style="border:none;" align="left"><italic>CL</italic>/<italic>F</italic></td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">133</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">96</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">renal clearance</td>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>r</sub>
              </td>
              <td style="border:none;" align="left">L/h/kg</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">401</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">35</td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">bioavailability</td>
              <td style="border:none;" align="left">
                <italic>F</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">243</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">35</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">32</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">others</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">33</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction absorbed</td>
              <td style="border:none;" align="left">
                <italic>F</italic>
                <sub>a</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">945</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">fraction excreted
in urine</td>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>e</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">343</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">excretion type in urine</td>
              <td style="border:none;" align="left">
                <italic>CR type</italic>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">27,505</td>
            </tr>
          </tbody>
        </table>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center"> </th>
              <th style="border:none;" align="center">parameter name</th>
              <th style="border:none;" align="center">parameter
type</th>
              <th style="border:none;" align="center">unit</th>
              <th style="border:none;" align="center">species</th>
              <th style="border:none;" align="center">data provided by accompanying
projects</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left">toxicity</td>
              <td style="border:none;" align="left">binding to hERG channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">9114</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding to Cav<sub>1.2</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">204</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding to Kv<sub>1.5</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">686</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">binding
to Nav<sub>1.5</sub> channel</td>
              <td style="border:none;" align="left">IC<sub>50</sub></td>
              <td style="border:none;" align="left">nM</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">1321</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">link to hepatotoxicity database DILI-cSEARCH</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human/rat</td>
              <td style="border:none;" align="left">620</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="tbl2" position="float">
        <label>Table 2</label>
        <caption>
          <title>List of the Prediction Models Implemented
in DruMAP</title>
        </caption>
        <table frame="hsides" rules="groups" border="0">
          <colgroup>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
            <col align="left"/>
          </colgroup>
          <thead>
            <tr>
              <th style="border:none;" align="center">parameter</th>
              <th style="border:none;" align="center">organism/cell/molecule</th>
              <th style="border:none;" align="center">type</th>
              <th style="border:none;" align="center">output</th>
              <th style="border:none;" align="center">accuracy</th>
              <th style="border:none;" align="center">method</th>
              <th style="border:none;" align="center">descriptor</th>
              <th style="border:none;" align="center">ref</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td style="border:none;" align="left"><italic>Sol</italic>(7.4).class</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;10 μg/mL), high (&gt;10 μg/mL)</td>
              <td style="border:none;" align="left">accuracy: 0.811,
kappa: 0.628</td>
              <td style="border:none;" align="left">L-SVM<xref rid="t2fn1" ref-type="table-fn">a</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>u,p</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0.001–0.05), medium (0.05–0.2), high (0.2–1.0)</td>
              <td style="border:none;" align="left">accuracy: 0.676, true positive
rate in low class: 0.826</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref11">11</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"><italic>R</italic><sup>2</sup> = 0.691</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>u,p</sub>.class</td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0.001–0.05), medium (0.05–0.2), high (0.2–1.0)</td>
              <td style="border:none;" align="left">kappa: 0.484</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,p</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">MSE = 1.70, <italic>R</italic><sup>2</sup> = 0.51</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>f</italic>
                <sub>u,brain</sub>
              </td>
              <td style="border:none;" align="left">mammal</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">MSE = 1.48, <italic>R</italic><sup>2</sup> = 0.58</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>CL</italic><sub>int</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">stable (&lt;20 μL/min/mg), moderate (20–300 μL/min/mg), unstable (&gt;300 μL/min/mg)</td>
              <td style="border:none;" align="left">accuracy: 0.771, kappa:
0.588</td>
              <td style="border:none;" align="left">R-SVM<xref rid="t2fn4" ref-type="table-fn">d</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref10">10</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>int</sub>
              </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">accuracy: 0.788</td>
              <td style="border:none;" align="left">LGBM<xref rid="t2fn5" ref-type="table-fn">e</xref></td>
              <td style="border:none;" align="left">Mordred, jCompoundMapper</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CYP.probability</td>
              <td style="border:none;" align="left">human
CYP1A2</td>
              <td style="border:none;" align="left">probability</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">accuracy: 0.617</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, RDKit</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP2C9</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy:
0.600</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP2D6</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy: 0.712</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP3A4</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">accuracy: 0.825</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left">CYP.site</td>
              <td style="border:none;" align="left">human CYP1A2</td>
              <td style="border:none;" align="left">site</td>
              <td style="border:none;" align="left">site</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref34">34</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">human CYP3A4</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref35">35</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>P</italic><sub>app(AtoB)</sub>.class</td>
              <td style="border:none;" align="left">human Caco-2</td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;100 nm/s), high (&gt; 100 nm/s)</td>
              <td style="border:none;" align="left">accuracy: 0.810, kappa: 0.601</td>
              <td style="border:none;" align="left">R-SVM<xref rid="t2fn4" ref-type="table-fn">d</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>P</italic>
                <sub>app(AtoB)</sub>
              </td>
              <td style="border:none;" align="left">human P-gp overexpressing LLC-PK1</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"><italic>R</italic><sup>2</sup> = 0.687</td>
              <td style="border:none;" align="left">linear stacking (LGBMe, XGBoost, Catboost, RF<xref rid="t2fn2" ref-type="table-fn">b</xref>, NN<xref rid="t2fn6" ref-type="table-fn">f</xref>)</td>
              <td style="border:none;" align="left">CDK, Mordred, jCompoundMapper,
RDKit</td>
              <td style="border:none;" align="left"> </td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>P-gp</italic><italic>NER</italic>.class</td>
              <td style="border:none;" align="left">human P-gp</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (&lt;1.4), medium (1.4–9.5), high
(&gt;9.5)</td>
              <td style="border:none;" align="left">kappa = 0.58</td>
              <td style="border:none;" align="left">GB<xref rid="t2fn3" ref-type="table-fn">c</xref></td>
              <td style="border:none;" align="left">Mordred,
jCompoundMapper</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>F</italic><sub>a</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">low (0–0.2), medium (0.2–0.7), high (0.7–1.0)</td>
              <td style="border:none;" align="left">accuracy: 0.836, kappa: 0.560</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">CDK, Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref14">14</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,brain</sub>
              </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">calculation</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>K</italic>
                <sub>p,uu,brain</sub>
              </td>
              <td style="border:none;" align="left">rat</td>
              <td style="border:none;" align="left">calculation</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left"> </td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref12">12</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left">
                <italic>CL</italic>
                <sub>r</sub>
              </td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">regression</td>
              <td style="border:none;" align="left">value</td>
              <td style="border:none;" align="left">in higher range of (more
than 0.0612 L/h/kg), 70.5% of samples
were fell in within 2-fold error</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref>, PLS<xref rid="t2fn7" ref-type="table-fn">g</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>f</italic><sub>e</sub>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">2 class</td>
              <td style="border:none;" align="left">low (&lt;0.3), medium-high (&gt;0.3)</td>
              <td style="border:none;" align="left">kappa: 0.49,
balanced accuracy: 0.74</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
            <tr>
              <td style="border:none;" align="left"><italic>CR_type</italic>.class</td>
              <td style="border:none;" align="left">human</td>
              <td style="border:none;" align="left">3 class</td>
              <td style="border:none;" align="left">reabsorption, secretion, intermediate</td>
              <td style="border:none;" align="left">kappa: 0.32, balanced accuracy: 0.70, 0.58 and 0.68 in reabsorption,
intermediate and secretion, respectively</td>
              <td style="border:none;" align="left">RF<xref rid="t2fn2" ref-type="table-fn">b</xref></td>
              <td style="border:none;" align="left">Mordred, PaDEL</td>
              <td style="border:none;" align="left">(<xref ref-type="bibr" rid="ref15">15</xref>)</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="t2fn1">
            <label>a</label>
            <p>L-SVM, linear support vector machine.</p>
          </fn>
          <fn id="t2fn2">
            <label>b</label>
            <p>RF, random forest.</p>
          </fn>
          <fn id="t2fn3">
            <label>c</label>
            <p>GB, gradient boosting.</p>
          </fn>
          <fn id="t2fn4">
            <label>d</label>
            <p>R-SVM, radial support vector machine.</p>
          </fn>
          <fn id="t2fn5">
            <label>e</label>
            <p>LGBM, light gradient boosting
machine.</p>
          </fn>
          <fn id="t2fn6">
            <label>f</label>
            <p>NN, neural network.</p>
          </fn>
          <fn id="t2fn7">
            <label>g</label>
            <p>PLS, partial least square.</p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
    </sec>
    <sec id="sec2.2">
      <title>Data Integration</title>
      <p>A unique feature of DruMAP is that
it provides a curated database, based on which the offered predictive
models were built. Furthermore, the database, containing data from
multiple public sources including ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> and drug approval-related documents, has been supplemented with
data obtained by in-house experiments, both <italic>in vitro</italic> and <italic>in vivo</italic> (see the <xref rid="sec4" ref-type="other">Experimental
Section</xref> for details). We assign unique identifiers to all entries
in DruMAP, where stereochemically related compounds and compounds
with different salts are grouped together and assigned identifiers
that reflect those relationships (see the <xref rid="sec4" ref-type="other">Experimental
Section</xref> for the identifier naming rules). The entries are cross-referenced
to popular databases, such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG
Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank,<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> but because of the grouping as mentioned above, the mapping
is not one-to-one, and DruMAP offers richer information on related
chemical structures than other databases. Each entry can also be accessed <italic>via</italic> TargetMine,<sup><xref ref-type="bibr" rid="ref18">18</xref></sup> an integrated
data warehouse for drug discovery.</p>
    </sec>
    <sec id="sec2.3">
      <title>Compound Search</title>
      <p>The compound search function (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>) provides various
query forms to search the DruMAP database using structure, activity,
property, compound name, or identifiers. For structure search, JSME
Molecular Editor<sup><xref ref-type="bibr" rid="ref19">19</xref></sup> was used to draw chemical
compounds in DruMAP (<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>A). Users can perform either a substructure or a similarity
search. The similarity score of a compound is calculated based on
the Tanimoto similarity coefficient of morgan fingerprints, using
the RDKit<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> morganbv_fp function. For an
activity or property search, users can create search expressions,
as will be described in the “Activity search” section
(<xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B). For a
name or identifier search, users can search for compounds by a list
of names, a list of identifiers (such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> identifiers in addition to DruMAP identifiers),
or a list of chemical structural descriptions (InChI or InChIKey,<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> SMILES,<sup><xref ref-type="bibr" rid="ref22">22</xref></sup> and MOL
or SDF files). Users can combine the above conditions by selecting
INTERSECT, UNION, or EXCEPT. The search results are shown as a list
of compounds with a link to the compound report view.</p>
      <fig id="fig2" position="float">
        <label>Figure 2</label>
        <caption>
          <p>Compound search, which
allows the user to select compounds based
on structure (A), activity, property, compound name, or identifiers
(B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0003" id="gr2" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.4">
      <title>Activity Search</title>
      <p>Activity search (<xref rid="fig3" ref-type="fig">Figure <xref rid="fig3" ref-type="fig">3</xref></xref>) provides an interface to search the DruMAP
database based on DruMAP identifiers, assay type, activity values,
or category of organisms, tissue, target molecule, route, dose, time,
parameter, or source. Users can edit conditional expressions to construct
a complex query. The search results are presented in a manner similar
to the compound search result view, but with activity data instead
of compound data.</p>
      <fig id="fig3" position="float">
        <label>Figure 3</label>
        <caption>
          <p>Activity search, which provides an interface for searching
the
DruMAP database based on the activity range, predicted category class,
or other data fields.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0004" id="gr3" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.5">
      <title>Compound Report</title>
      <p>Compound report (<xref rid="fig4" ref-type="fig">Figure <xref rid="fig4" ref-type="fig">4</xref></xref>) can be accessed from the search results
of compound search or activity search. It shows all data related to
an individual compound. There are 11 subsections in this view: “Top,”
“Structures,” “Chemical spaces,” “Related
compounds,” “External links,” “Physicochemical
properties,” “Activities (physicochemical),”
“Activities (<italic>in vitr</italic>o),” “Activities
(<italic>in vivo</italic>),” “Activities (prediction),”
and “Toxicity.” The “Top” section of this
view has basic information, including compound names, synonyms, molecular
formulae, salt, molecular weights, and the exact mass of the most
abundant atomic species. The “Structures” section provides
a text format of the compound structure, such as SMILES, InChI, or
InChIKey. The “Chemical space” section shows the position
of the designated compound in the collection of compounds registered
in DruMAP. Users can change the <italic>x</italic>-axis or <italic>y</italic>-axis parameters as per their preference. The “Related
compound” section provides links to the compounds with different
salts or stereoisomers. The “External links” section
provides links to external databases, such as ChEMBL,<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> KEGG Drug,<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> and DrugBank.<sup><xref ref-type="bibr" rid="ref17">17</xref></sup> The “Physicochemical properties”
section collects basic physicochemical properties calculated using
RDKit.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> The three “Activities”
sections provide curated public or experimentally obtained data for
each category. By default, the activity data for related compounds
are displayed with the specified compound and can be turned off by
clearing the “include related compounds” check box.
If there are time-dependent concentration data in plasma or tissues,
a line graph showing the time-dependent curve is displayed along with
the table. Each line can be turned on or off by checking or clearing
the check boxes in the table. The “Activities (prediction)”
section provides data predicted by our prediction programs for a maximum
of 23 DMPK parameters. Finally, the “Toxicity” section
has links, if any, to cardiotoxicity<sup><xref ref-type="bibr" rid="ref23">23</xref></sup> or
hepatotoxicity<sup><xref ref-type="bibr" rid="ref24">24</xref></sup> data generated in other
related projects (<uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.id3inst.org/">https://www.id3inst.org/</uri>).</p>
      <fig id="fig4" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Compound report, which provides all data relevant to the compound
searched <italic>via</italic> the compound or activity search functions.</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0005" id="gr4" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.6">
      <title>New Prediction</title>
      <p>New prediction (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>A) provides an interface to predict DMPK
parameters solely from user-provided structural information of compounds
in SDF (Structural Data File) or the SMILES format. To date, we have
constructed 23 prediction models and are working on several other
models. Details of the methods used to construct these models have
been published<sup><xref ref-type="bibr" rid="ref10">10</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup> or will be published elsewhere. <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> lists the models that we prepared. These
prediction models have been integrated to DruMAP, and the users can
predict DMPK parameters for up to 30 compounds simultaneously. For
the prediction of <italic>K</italic><sub>p,brain</sub> and <italic>K</italic><sub>p,uu,brain</sub>, log <italic>P</italic> and
acidic/basic p<italic>K</italic><sub>a</sub> values are required in
addition to the compound structure information. The user may enter
any known values of log <italic>P</italic> and acidic/basic p<italic>K</italic><sub>a</sub> in the appeared input field; if the input
field is left blank, the log <italic>P</italic> value calculated using
RDKit and the p<italic>K</italic><sub>a</sub> value calculated using
ChemAxon Calculator Plugins (Chemaxon, Budapest, Hungary) will be
substituted to the prediction of <italic>K</italic><sub>p,brain</sub> and <italic>K</italic><sub>p,uu,brain</sub>. The prediction results
are presented in a tabular format (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B). The chemical space of the compounds by
principal component analysis (PCA) with descriptors that are used
for the construction of each prediction model is displayed along with
the position of the compound to be predicted (currently available
only for <italic>f</italic><sub>u,p</sub>, <italic>f</italic><sub>u,brain</sub>, <italic>f</italic><sub>e</sub>, and the type of the
clearance ratio, <italic>CR_type</italic>).</p>
      <fig id="fig5" position="float">
        <label>Figure 5</label>
        <caption>
          <p>New prediction, which
provides an interface for predicting DMPK
parameters from user-provided compounds (A). Prediction results are
presented in a tabular format with a chemical space graph when available
(B).</p>
        </caption>
        <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_0006" id="gr5" position="float"/>
      </fig>
    </sec>
    <sec id="sec2.7">
      <title>Case Study 1</title>
      <p>One of the most common uses of DruMAP
is to comprehensively view DMPK data of a compound, including DruMAP-predicted
data. In what follows, we explain how to use DruMAP, using propranolol
hydrochloride as an example.</p>
      <p>First, click on “Compound
search” on the top page of the DruMAP web application. Then,
a form for entering search conditions will be displayed. Select “Name”
and input “propranolol” (or only “propr”)
in the input box, then click on the “Search” button.
Click on “propranolol hydrochloride” from the search
results listed.</p>
      <p>On the “Compound report” page,
one can view all the
information about propranolol hydrochloride or its desalted form,
propranolol, as described in the “Compound report” section.
At the top, one can see the compound’s DruMAP identifier (DIJ0000210800-01)
and examine its basic properties. In the “Chemical space”
section, one can select the <italic>x</italic>-axis to be “Freebase
molecular weight” and the <italic>y</italic>-axis to be “PSA”
(polar surface area), which reveals that this compound (shown in red)
is situated in the bottom left part of the chemical space spanned
by all DruMAP entries.</p>
      <p>Furthermore, users can view all activity
data obtained through <italic>in vitro</italic> experiments in “Activities
(<italic>in vitro</italic>)” section. For example, the human
fraction unbound in the
plasma (<italic>f</italic><sub>u,p</sub>) value is 0.169 in the NIBIOHN
source (our in-house experiments) and 0.100 in the ChEMBL source.
Furthermore, users can view activity data obtained through <italic>in vivo</italic> experiments in the “Activities (<italic>in
vivo</italic>)” section. For example, one can view time-dependent
plasma concentrations of the drug and the pharmacokinetic parameters
calculated from them, such as elimination half-life in plasma (<italic>T</italic><sub>1/2</sub>) or the apparent volume of distribution
at a steady state (<italic>Vd</italic><sub>ss</sub><italic>/F</italic>) after intravenous injection (<italic>i.v.</italic>) of the drug
into male Sprague–Dawley (SD) rats in no. 1 of the table. As
time-dependent concentration data in plasma and tissues are available
for this compound, a line graph showing the time-dependent curve is
displayed along with the table. By clearing the check box at the top
of the activity table (just left of “no.”) and checking
nos. 1 and 4, one can visually check the time-dependent concentrations
in plasma and brain, which reveals that this compound is well translocated
into the brain.</p>
      <p>Finally, one can view the data predicted by
our prediction programs
in the “Activities (prediction)” section. For example, <italic>f</italic><sub>u,p</sub> and <italic>CL</italic><sub>int</sub> values
in humans are 0.140 and 15.1 μL/min/mg, respectively.</p>
    </sec>
    <sec id="sec2.8">
      <title>Case Study 2</title>
      <p>Another useful use of DruMAP is to select
the appropriate compounds that meet several conditions. Here, as an
example, we explain how to select compounds that are expected to have
metabolic stability and excellent transferability to the central nervous
system.</p>
      <p>First, click on “Compound search” on the
top page of DruMAP. Then, select “Activity” from the
list box, and click on the “Set conditions” button.
A pop-up window similar to the activity search will appear, and use
the “Add rule” button to create a search expression
as shown in <xref rid="fig2" ref-type="fig">Figure <xref rid="fig2" ref-type="fig">2</xref></xref>B. The “Add group” button allows the user to define
multiple compound sets with any desired properties. Multiple conditions
can be set and combined to filter compounds according to the user’s
preferred conditions. Click on the “Apply” button to
set the search conditions, and the search conditions will be displayed
under the “Set conditions” button. Finally, compounds
can be filtered according to the setting after the “Search”
button is clicked on.</p>
      <p>The following is an example of searching
for compounds that are
metabolically stable, non-substrates for P-gp (P-glycoprotein), and
migratable to the brain. First, click on “Add group”
three times and set three empty compound sets with selecting “intersect”.
Then, set conditions in activity for each of the three compound sets
with the following conditions. Conditions 1 are Source = “DruMAP
prediction” AND organism = “human” AND parameter
= “<italic>CL</italic>int.class” AND Activity value
(Class) = “Stable”, conditions 2 are Source = “DruMAP
prediction” AND organism = “human” AND target
molecule = “P-gp” AND parameter = “NER.class”
AND Activity value (Class) = “Low”, conditions 3 are
Source = “DruMAP prediction” AND organism = “rat”
AND tissue = “brain” AND parameter = “Kp,uu”
AND activity value ≥0.5. This search expression will return
compounds, for which human <italic>CL</italic><sub>int</sub>.class
is “Stable,” human <italic>P-gp NER</italic>.class is
“Low” and rat <italic>K</italic><sub>p,uu,brain</sub> ≥ 0.5. In DruMAP, human <italic>CL</italic><sub>int</sub> is classified into “Stable” (&lt;20 μL/min/mg),
“Moderate” (20–300 μL/min/mg), and “Unstable”
(&gt;300 μL/min/mg), and <italic>P-gp NER</italic>.class is
classified
into “Low” (1–1.4), “Medium” (1.4–9.8),
and “High” (&gt;9.8). <italic>K</italic><sub>p,uu,brain</sub> represents the ratio of the concentration of unbound compound in
the brain and plasma, and, as human <italic>K</italic><sub>p,uu,brain</sub> data are unavailable, we used rat data instead. Finally, by clicking
on the “Search” button, the compounds in all conditions
1–3 can be obtained.</p>
      <p>The search results will be shown
below the search expression. The
current version of DruMAP returns 2840 candidate compounds. The user
can further filter the results by adding a property or structure search.
For example, selecting the “substructure” option in
the structure search and drawing a substructure results in less compounds
remaining. The user can examine each of those compounds by clicking
on the corresponding row.</p>
      <p>The user can thus create a list of
compounds that meet the search
conditions and export the DruMAP identifier list by clicking on “Download
ID list”, then perform an activity search by uploading the
list of DruMAP identifiers. In this way, it can be possible to find
a group of chemical compounds with suitable pharmacokinetic properties.
Alternatively, the user can save a list of compounds that meet the
search conditions and use it to create a compound library for a high-throughput
screening of new drugs.</p>
    </sec>
    <sec id="sec2.9">
      <title>Case Study 3</title>
      <p>The next case aimed to design a compound
with appropriate properties based on a compound not found in DruMAP.
Suppose you have compound A whose SMILES structure is “O=c1c(F)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12.”
You can identify similar compounds <italic>via</italic> the following
steps: select “Structure” and “Similarity”
in the “Compound search,” and click on “Draw
structure.” Then, click on the blue up-down triangles at the
top of the chemical input box, click on “Paste MOL or SDF or
SMILES,” paste the SMILES structure of compound A in the input
box, click on “Accept,” and click on “Apply.”
You can also input the SMILES structure in the “Draw structure”
box. Then, set the threshold to 0.5, and click on “Search.”
The search result field shows four compounds: kaempferol, luteolin,
morin, and quercetin. You can view their prediction values by clicking
on each compound. For <italic>K</italic><sub>p,uu,brain</sub>, the
values are 0.172, 0.237, 0.042, and 0.059, respectively. Then, you
can alter certain residues to design new compounds. After saving the
structures as SDF or SMILES, you can load them on the “New
prediction” page. After placing a check mark in the “<italic>K</italic><sub>p,brain</sub><italic>K</italic><sub>p,uu,brain</sub>” line, press “Calculate” to display the prediction
results (<xref rid="fig5" ref-type="fig">Figure <xref rid="fig5" ref-type="fig">5</xref></xref>B).
This will identify compounds with higher (“O=c1c(Cl)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12,”
0.598) and lower <italic>K</italic><sub>p,uu,brain</sub> values (“O=C1c2c(O)cc(O)cc2OC(c2ccc(O)c(O)c2O)C1O,”
0.022) among the similar compounds than the starting compound (0.219).</p>
    </sec>
  </sec>
  <sec id="sec3">
    <title>Discussion and Conclusions</title>
    <p>We have released a platform
named DruMAP that consists of a database
and an associated prediction system. The database contains curated
public and in-house data used for the construction of prediction models
for various pharmacokinetic parameters from absorption to secretion,
such as <italic>D-Sol</italic>, <italic>f</italic><sub>u,p</sub>, <italic>f</italic><sub>u,brain</sub>, <italic>CL</italic><sub>int</sub>,
permeability coefficient for Caco-2 cells, <italic>CL</italic><sub>r</sub>, <italic>F</italic><sub>a</sub>, and <italic>f</italic><sub>e</sub>. In addition, it contains prediction results for more than
27,000 compounds, pre-calculated using our prediction models. The
user can search the database by keywords, compound identifiers, structural
descriptions such as InChI or SMILES, and parameter values. Furthermore,
DruMAP can predict DMPK parameters for user-input compounds using
our prediction programs. This platform is useful for early DMPK studies
and candidate compound selection to accelerate novel drug development.</p>
    <p>There are several tools and software programs dealing with pharmacokinetic
prediction. Among them, SwissADME,<sup><xref ref-type="bibr" rid="ref3">3</xref></sup> pkCSM,<sup><xref ref-type="bibr" rid="ref5">5</xref></sup> and ADMETlab<sup><xref ref-type="bibr" rid="ref6">6</xref></sup> have
a similar concept as that of DruMAP. They can also predict many physicochemical
and pharmacokinetic parameters from a chemical structure. DruMAP can
predict parameter values such as <italic>CL</italic><sub>int</sub>, <italic>CL</italic><sub>r</sub>, <italic>f</italic><sub>e</sub>, and <italic>K</italic><sub>p,uu,brain</sub> that are not available
in SwissADME, pkCSM, and ADMETlab. We have not generated prediction
models for CYP inhibition; however, we plan to include them in a future
version. Moreover, DruMAP stores results precalculated by our prediction
models for many compounds, and a very flexible filtering system is
available, allowing users to define filters for compounds fit for
their purposes, as described in Case Study 2. We plan to extend the
compound data in DruMAP to commercially available compounds and all
organic compounds in the ChEMBL database with molecular weights less
than 2000 Da in their salt-free form. Then, DruMAP could be used as
a pre-screening tool for better pharmacological profiles from tens
of millions of library compounds.</p>
    <p>The most important factor
to create accurate prediction models
is to collect high-quality experimental data as much as possible.
To this end, we have established a consortium with seven pharmaceutical
companies and obtained chemical descriptors and experimental data
for several pharmacokinetic parameters from these companies,<sup><xref ref-type="bibr" rid="ref25">25</xref>,<xref ref-type="bibr" rid="ref26">26</xref></sup> although these data are proprietary to the companies and we cannot
provide them in DruMAP. Another approach to increase experimental
data is to collect data from documents on new drug applications, such
as Common Technical Document (CTD), package inserts, or Interview
Form (IF), which is a supplementary document of the package insert
of a launched drug specifically in Japan. These documents are publicly
available from the Pharmaceuticals and Medical Devices Agency (PMDA).
However, these documents are not well structured, and some of them
are not in text format but in image format; thus, it is nearly impossible
to use them as-is. We started digitizing these data and incorporating
them into the DruMAP database. At present, we have stored only a limited
number of DMPK data from CTD and IF, but we are planning to comprehensively
collect these data. Afterwards, we will create more models for other
DMPK parameters.</p>
    <p>In conclusion, DruMAP enables searching experimental
and predicted
DMPK data and predicting DMPK parameters for novel compounds. We continue
to develop the DruMAP system to improve its functions. We hope that
DruMAP can contribute to the acceleration of new drug discovery.</p>
  </sec>
  <sec id="sec4">
    <title>Experimental Section</title>
    <sec id="sec4.1">
      <title>Chemical Compounds Registered in the DruMAP Database</title>
      <p>DruMAP includes organic compounds with molecular weights less than
2000 Da in their salt-free form. All chemicals in KEGG Drug<sup><xref ref-type="bibr" rid="ref16">16</xref></sup> that do not fall into this category, such as
combination drugs, inorganic compounds, and macromolecular compounds,
were excluded. DruMAP distinguishes compounds with different salts
while ignoring the water of crystallization and solvents such as ethanol
and acetone. In addition, compounds that can be interconverted in
aqueous solution were summarized under one compound identifier.</p>
      <p>We have given compounds our own identifier, drumap_id. It consists
of a three-letter prefix (“DIJ”) and a ten-digit number
followed by a two-digit number that indicates stereoisomers, a hyphen
(“-”), and a two-digit number. We defined the first
11 characters as the compound core identifier. The last two-digit
number is used to discriminate salt differences, and “00”
is used for chemicals without salt. The two-digit number immediately
before the hyphen is used to discriminate between enantiomers and
diastereomers. These four digits do not affect the calculation of
physicochemical properties. Furthermore, they do not affect the calculation
of descriptors because we used two dimensional descriptors for the
development of the prediction models. The current version of DruMAP
(1.5) contains 30,971 compounds, of which 27,500 are salt-free and
3471 contain salts. On ignoring salts and stereoisomerism, the number
of compounds is 25,622.</p>
    </sec>
    <sec id="sec4.2">
      <title>Chemicals Used in <italic>In Vitro</italic> and <italic>In Vivo</italic> Experiments</title>
      <p>Chemicals used in the experiments were commercially
available compounds with guaranteed purity (&gt;95%) and purchased
from
Abcam (Cambridge, UK), AdooQ Bioscience (Irvine, CA, USA), Advanced
ChemBlocks (Burlingame, CA, USA), Alomone Labs (Jerusalem, Israel),
AN PharmaTech (Shanghai, China), Ark Pharm (Arlington Heights, IL,
USA), AvaChem Scientific (San Antonio, TX, USA), Bachem (Bubendorf,
Switzerland), Carbosynth (Berkshire, UK), Cayman Chemical (Ann Arbor,
MI, USA), Chem-Impex International (Wood Dale, IL, USA), ChemScene
(Monmouth Junction, NJ, USA), Combi-Blocks (San Diego, CA, USA), Corning
(New York, NY, USA), EDQM Council of Europe (Strasbourg, France),
Enamine (Monmouth Junction, NJ, USA), eNovation Chemicals (Green Brook,
NJ, USA), Fujifilm Wako Pure Chemical (Osaka, Japan), LC Laboratories
(Woburn, MA, USA), Life Chemicals (Burlington, Canada), LKT Laboratories
(St. Paul, MN, USA), Maybridge (Leicestershire, UK), MedChem Express
(Princeton, NJ, USA), Pharmeks (Moscow, Russia), Santa Cruz Biotechnology
(Dallas, TX, USA), Selleck Chemicals (Houston, TX, USA), Shanghai
BioChemPartner (Wuhan, China), Sigma-Aldrich (St. Louis, MO, USA),
Specs (Zoetermeer, The Netherlands), Target Molecule (Wellesley Hills,
MA, USA), TLC Pharmaceutical Standards (Aurora, Canada), Tocris Bioscience
(Bristol, UK), Tokyo Chemical Industry (Tokyo, Japan), Toronto Research
Chemicals (Toronto, Canada), The United States Pharmacopeial Convention
(Rockville, MD, USA), and Vitas M Chemical (Causeway Bay, Hong Kong).</p>
    </sec>
    <sec id="sec4.3">
      <title><italic>In Vitro</italic> Experimental Data Collection</title>
      <p>Solubilities at pH 7.4 and pH 1.2 (<italic>D-Sol</italic><sub>7.4</sub> and <italic>D-Sol</italic><sub>1.2</sub>) at 25 °C were measured
using the dried-DMSO method.<sup><xref ref-type="bibr" rid="ref14">14</xref></sup> We also
measured the distribution coefficient at pH 7.4 (log <italic>D</italic><sub>7.4</sub>) at 25 °C. These parameters are known to affect
the absorption and renal excretion of drugs. The fraction unbound
in plasma (<italic>f</italic><sub>u,p</sub>) determines drug efficacy
because only the unbound drug is capable of interacting with target
proteins and is able to diffuse between plasma and tissues. The <italic>f</italic><sub>u,p</sub> values were calculated from the drug concentrations
in plasma and in phosphate-buffered saline (PBS) after incubation
of the drug with human or rat plasma, separated from PBS using a dialysis
membrane. The fraction unbound in brain homogenate (<italic>f</italic><sub>u,brain</sub>) provides an estimate of the amount of unbound
drug in the central nervous system. The <italic>f</italic><sub>u,brain</sub> value was calculated from the drug concentration in brain homogenate
and in PBS after incubation of the drug with rat brain homogenate,
separated from PBS using a dialysis membrane. The <italic>CL</italic><sub>int</sub> values were calculated from the slope of the plot
of log-transformed drug concentration <italic>versus</italic> time
after incubation with human or rat liver microsomes (Sekisui XenoTech,
Kansas City, KS, USA). All experiments were carried out at Sumika
Chemical Analysis Service (SCAS, Osaka, Japan).</p>
    </sec>
    <sec id="sec4.4">
      <title><italic>In Vivo</italic> Experimental Data Collection</title>
      <p>We measured drug concentrations in plasma and tissues (brain, cerebrospinal
fluid, heart, lungs, liver, kidneys, and muscle) after intravenous
(<italic>i.v.</italic>) or per oral (<italic>p.o.</italic>) administration
of a drug in Crl/CD (SD) male rats (Jackson Laboratory Japan, Yokohama,
Japan). The following pharmacokinetic parameters were calculated using
Phoenix WinNonlin version 8.1 (Certara, Princeton, NJ, USA): initial
concentration (<italic>C</italic><sub>0</sub>), peak concentration
(<italic>C</italic><sub>max</sub>), elimination half-life (<italic>T</italic><sub>1/2</sub>), time to reach maximum concentration (<italic>T</italic><sub>max</sub>), area under the concentration–time
curve from zero to the last sampling time (AUC<sub>0–<italic>t</italic></sub>), area under the concentration–time curve
from zero to infinity (AUC<sub>inf</sub>), apparent volume of distribution
at steady state (<italic>V</italic><sub>dss</sub>), total clearance
(<italic>CL</italic>), mean residence time from zero to infinity (MRT<sub>inf</sub>) for <italic>i.v.</italic> administration and <italic>C</italic><sub>max</sub>, <italic>T</italic><sub>1/2</sub>, <italic>T</italic><sub>max</sub>, AUC<sub>0–<italic>t</italic></sub>, AUC<sub>inf</sub>, apparent volume of distribution during the terminal phase
(<italic>V</italic><sub>z</sub><italic>/F</italic>), apparent total
clearance (<italic>CL</italic>/<italic>F</italic>), and MRT<sub>inf</sub> for <italic>p.o.</italic> administration. Tissue plasma partition
coefficients (<italic>K</italic><sub>p,tissue</sub>) were calculated
for the seven tissues by dividing each tissue concentration by the
plasma concentration at a steady state. When both <italic>i.v.</italic> and <italic>p.o.</italic> data were measured for a compound, bioavailability
(<italic>F</italic>) was calculated using <xref rid="eq1" ref-type="disp-formula">eq <xref rid="eq1" ref-type="disp-formula">1</xref></xref>, where <italic>D</italic> is the administration
dose.<disp-formula id="eq1"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_m001" position="anchor"/><label>1</label></disp-formula></p>
      <p>We also measured drug concentrations
in plasma, brain, and cerebrospinal fluid after <italic>i.v.</italic> or <italic>p.o.</italic> drug administration in <italic>Abcb1a</italic> (<italic>Mdr1a</italic>) and <italic>Abcb1b</italic> (<italic>Mdr1b</italic>) knock-out SD-(<italic>Abcb1a-Abcb1b</italic>)<sup><italic>em1Sage</italic></sup> male rats (Horizon Discovery, Boyertown, PA, USA). A cocktail
of five compounds was administered. All experiments using rats were
carried out at Shin Nippon Biomedical Laboratories (SNBL, Tokyo, Japan)
under the approval of the Institutional Animal Care and Use Committee
of NIBIOHN and SNBL. All experiments using SD-(<italic>Abcb1a-Abcb1b</italic>)<sup><italic>em1Sage</italic></sup> rats were carried out under
the approval of the Recombinant Gene Experiment Safety Committee of
SNBL.</p>
    </sec>
    <sec id="sec4.5">
      <title>Public Data Collection</title>
      <p>Public data were extracted from
ChEMBL<sup><xref ref-type="bibr" rid="ref8">8</xref></sup> version 30, Interview Forms downloaded
from PMDA in Japan (which included supplementary documents of package
inserts of launched drugs), a summary of CTDs downloaded from PMDA,
and from articles describing DMPK data.<sup><xref ref-type="bibr" rid="ref27">27</xref>−<xref ref-type="bibr" rid="ref31">31</xref></sup></p>
    </sec>
    <sec id="sec4.6">
      <title>Data Curation</title>
      <p>All data were manually curated. The curation
process included standardization of units; however, other important
factors must also be considered. For example, we collected data of
fractions unbound in plasma, but ChEMBL also contains data of fractions
that are bound. In this case, the fraction must be subtracted from
1 to convert the data to fraction-unbound form. Moreover, hepatic
intrinsic clearance is usually expressed as the rate of metabolism
per 1 mg of hepatic microsomal protein. A similar parameter, hepatic
clearance, is usually expressed as the rate of metabolism per 1 g
of liver or per 1 kg of body weight. To obtain hepatic intrinsic clearance
values, hepatic clearance should be converted using liver weight per
kg of body mass and hepatic microsome weight per g of liver. A key
issue is that hepatic clearance and hepatic intrinsic clearance are
sometimes not correctly annotated in the ChEMBL database, leading
to inappropriate conversion. Details on the curation process have
been described in the respective articles on the prediction models.<sup><xref ref-type="bibr" rid="ref10">10</xref>−<xref ref-type="bibr" rid="ref15">15</xref></sup></p>
    </sec>
    <sec id="sec4.7">
      <title>Data Processing</title>
      <p>To use the activity value data for
machine learning, it is necessary to set one activity value per compound
for each parameter. We defined the representative activity value as
follows. We assigned data categories to all the activity data, and
if there was only one activity data for one parameter and one compound
ignoring salts, the data were assigned as data category 1. If there
were two or more data for one parameter and one compound, we assigned
representative activity values as follows. We assigned data category
4 to ambiguous data, such as those with the word “about”
or those that were expressed as a range of activities appearing mostly
in Interview Forms, and data category 3 to other data. If there was
only one category 3 data, the data were assigned as category 2, and
if there were two or more category 3 data, the geometric mean value
and geometric standard deviation were calculated to assign them as
category 2 data. If there were no category 3 data, category 4 data
were used as category 2 data. All category 1 and category 2 data were
used as representative activity data in the DruMAP system.</p>
    </sec>
    <sec id="sec4.8">
      <title>Structure Data</title>
      <p>We stored chemical structures as the
SMILES format standardized using the ChEMBL structure pipeline.<sup><xref ref-type="bibr" rid="ref32">32</xref></sup> The SMILES was converted to the InChI<sup><xref ref-type="bibr" rid="ref21">21</xref></sup> format to summarize tautomers using RDKit.<sup><xref ref-type="bibr" rid="ref20">20</xref></sup> InChI descriptions can summarize most of the
tautomers. Tautomers that could not be summarized using InChI descriptions
were managed using a different tautomer identifier for the same compound.
To calculate prediction values, we needed the chemical descriptors
shown in <xref rid="tbl2" ref-type="other">Table <xref rid="tbl2" ref-type="other">2</xref></xref> for
each parameter. The SMILES of a compound was converted into MOL format
using Open Babel 3.1.0<sup><xref ref-type="bibr" rid="ref33">33</xref></sup> to calculate these
descriptors. The MolDraw2DSVG function of RDKit was used for drawing
the chemical structure.</p>
    </sec>
    <sec id="sec4.9">
      <title>Database Schema</title>
      <p>The curated public data, our experimental
and predicted data, and chemical data were stored in a PostgreSQL
database. A schema of the DruMAP database is presented in Supplementary <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.3c00481/suppl_file/jm3c00481_si_001.pdf">Figure S1</ext-link>.</p>
    </sec>
    <sec id="sec4.10">
      <title>Compound Search in DruMAP</title>
      <p>Partial matching of query
strings with the ILIKE operator (case-insensitive) in PostgreSQL was
used for chemical name searches. An RDKit PostgreSQL Cartridge was
used for substructure and similarity searches of the compounds.</p>
    </sec>
  </sec>
</body>
<back>
  <notes id="notes1" notes-type="si">
    <title>Supporting Information Available</title>
    <p>The Supporting Information
is
available free of charge at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00481?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.3c00481</ext-link>.<list id="silist" list-type="simple"><list-item><p>PostgreSQL schema of the DruMAP database (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://pubs.acs.org/doi/suppl/10.1021/acs.jmedchem.3c00481/suppl_file/jm3c00481_si_001.pdf">PDF</ext-link>)</p></list-item></list></p>
  </notes>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material content-type="local-data" id="sifile1">
      <media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="jm3c00481_si_001.pdf">
        <caption>
          <p>jm3c00481_si_001.pdf</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
  <notes notes-type="" id="notes2">
    <title>Author Contributions</title>
    <p>H.Ka. and
R.W. contributed equally. K.M. designed and supervised the entire
study, and all authors planned the study; H.Ka. designed the database
schema, entered data into the DruMAP database, and wrote the manuscript;
R.W. collected the public data, constructed the prediction models,
and wrote the manuscript; T.E. and M.K. collected the public data
and constructed the prediction models; R.O. and H.Ko. provided guidance
on the pharmacokinetics section. All authors read and approved the
manuscript.</p>
  </notes>
  <notes notes-type="COI-statement" id="NOTES-d14e2255-autogenerated">
    <p>The authors declare
no
competing financial interest.</p>
  </notes>
  <ack>
    <title>Acknowledgments</title>
    <p>This study was supported by the Japan Agency for
Medical Research and Development (AMED) under grant numbers JP15nk0101101
and JP20nk0101111. We thank D. Sato (Lifematics, Tokyo, Japan) for
the development of the web interface, J. Ohori and H. Koga (Fujitsu,
Tokyo, Japan) for the development of the prediction programs for CYP
metabolism, Y. Hori and K. Kamiya (SyntheticGestalt, Tokyo, Japan)
for the development of the <italic>CL</italic><sub>int</sub> regression
model, and Y. Yanagihashi (Lifematics) for the development of the
LLC-PK1 Papp model. We also thank L. P. Tripathi for the naming of
DruMAP. We would like to thank Editage for English language editing.</p>
  </ack>
  <glossary id="dl1">
    <def-list>
      <title>Abbreviations</title>
      <def-item>
        <term>AMED</term>
        <def>
          <p>Japan
Agency for Medical Research
and Development</p>
        </def>
      </def-item>
      <def-item>
        <term>AUC</term>
        <def>
          <p>area under the drug concentration–time curve</p>
        </def>
      </def-item>
      <def-item>
        <term>CTD</term>
        <def>
          <p>common technical document</p>
        </def>
      </def-item>
      <def-item>
        <term>CYP</term>
        <def>
          <p>cytochrome P-450</p>
        </def>
      </def-item>
      <def-item>
        <term>DMPK</term>
        <def>
          <p>drug metabolism
and pharmacokinetics</p>
        </def>
      </def-item>
      <def-item>
        <term>IF</term>
        <def>
          <p>interview form</p>
        </def>
      </def-item>
      <def-item>
        <term>i.v.</term>
        <def>
          <p>intravenous</p>
        </def>
      </def-item>
      <def-item>
        <term>NER</term>
        <def>
          <p>net efflux ratio</p>
        </def>
      </def-item>
      <def-item>
        <term>PBS</term>
        <def>
          <p>phosphate-buffered saline</p>
        </def>
      </def-item>
      <def-item>
        <term>P-gp</term>
        <def>
          <p>P-glycoprotein</p>
        </def>
      </def-item>
      <def-item>
        <term>PMDA</term>
        <def>
          <p>Pharmaceuticals and Medical Devices Agency</p>
        </def>
      </def-item>
      <def-item>
        <term>p.o.</term>
        <def>
          <p>per oral</p>
        </def>
      </def-item>
      <def-item>
        <term>SD</term>
        <def>
          <p>Sprague–Dawley</p>
        </def>
      </def-item>
    </def-list>
  </glossary>
  <ref-list>
    <title>References</title>
    <ref id="ref1">
      <mixed-citation publication-type="journal" id="cit1"><name><surname>Chan</surname><given-names>H. S.</given-names></name>; <name><surname>Shan</surname><given-names>H.</given-names></name>; <name><surname>Dahoun</surname><given-names>T.</given-names></name>; <name><surname>Vogel</surname><given-names>H.</given-names></name>; <name><surname>Yuan</surname><given-names>S.</given-names></name><article-title>Advancing
drug discovery via artificial intelligence</article-title>. <source>Trends Pharmacol. Sci.</source><year>2019</year>, <volume>40</volume>, <fpage>592</fpage>–<lpage>604</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2019.06.004</pub-id>.<pub-id pub-id-type="pmid">31320117</pub-id></mixed-citation>
    </ref>
    <ref id="ref2">
      <mixed-citation publication-type="journal" id="cit2"><name><surname>Shamas-Din</surname><given-names>A.</given-names></name>; <name><surname>Schimmer</surname><given-names>A. D.</given-names></name><article-title>Drug discovery in
academia</article-title>. <source>Exp.
Hematol.</source><year>2015</year>, <volume>43</volume>, <fpage>713</fpage>–<lpage>717</lpage>. <pub-id pub-id-type="doi">10.1016/j.exphem.2015.02.007</pub-id>.<pub-id pub-id-type="pmid">25912018</pub-id></mixed-citation>
    </ref>
    <ref id="ref3">
      <mixed-citation publication-type="journal" id="cit3"><name><surname>Daina</surname><given-names>A.</given-names></name>; <name><surname>Michielin</surname><given-names>O.</given-names></name>; <name><surname>Zoete</surname><given-names>V.</given-names></name><article-title>SwissADME: a free web tool to evaluate
pharmacokinetics, drug-likeness and medicinal chemistry friendliness
of small molecules</article-title>. <source>Sci. Rep.</source><year>2017</year>, <volume>7</volume>, <fpage>42717</fpage><pub-id pub-id-type="doi">10.1038/srep42717</pub-id>.<pub-id pub-id-type="pmid">28256516</pub-id></mixed-citation>
    </ref>
    <ref id="ref4">
      <mixed-citation publication-type="journal" id="cit4"><name><surname>Sushko</surname><given-names>I.</given-names></name>; <name><surname>Novotarskyi</surname><given-names>S.</given-names></name>; <name><surname>Körner</surname><given-names>R.</given-names></name>; <name><surname>Pandey</surname><given-names>A. K.</given-names></name>; <name><surname>Rupp</surname><given-names>M.</given-names></name>; <name><surname>Teetz</surname><given-names>W.</given-names></name>; <name><surname>Brandmaier</surname><given-names>S.</given-names></name>; <name><surname>Abdelaziz</surname><given-names>A.</given-names></name>; <name><surname>Prokopenko</surname><given-names>V. V.</given-names></name>; <name><surname>Tanchuk</surname><given-names>V. Y.</given-names></name>; <name><surname>Todeschini</surname><given-names>R.</given-names></name>; <name><surname>Varnek</surname><given-names>A.</given-names></name>; <name><surname>Marcou</surname><given-names>G.</given-names></name>; <name><surname>Ertl</surname><given-names>P.</given-names></name>; <name><surname>Potemkin</surname><given-names>V.</given-names></name>; <name><surname>Grishina</surname><given-names>M.</given-names></name>; <name><surname>Gasteiger</surname><given-names>J.</given-names></name>; <name><surname>Schwab</surname><given-names>C.</given-names></name>; <name><surname>Baskin</surname><given-names>I. I.</given-names></name>; <name><surname>Palyulin</surname><given-names>V. A.</given-names></name>; <name><surname>Radchenko</surname><given-names>E. V.</given-names></name>; <name><surname>Welsh</surname><given-names>W. J.</given-names></name>; <name><surname>Kholodovych</surname><given-names>V.</given-names></name>; <name><surname>Chekmarev</surname><given-names>D.</given-names></name>; <name><surname>Cherkasov</surname><given-names>A.</given-names></name>; <name><surname>Aires-de-Sousa</surname><given-names>J.</given-names></name>; <name><surname>Zhang</surname><given-names>Q. Y.</given-names></name>; <name><surname>Bender</surname><given-names>A.</given-names></name>; <name><surname>Nigsch</surname><given-names>F.</given-names></name>; <name><surname>Patiny</surname><given-names>L.</given-names></name>; <name><surname>Williams</surname><given-names>A.</given-names></name>; <name><surname>Tkachenko</surname><given-names>V.</given-names></name>; <name><surname>Tetko</surname><given-names>I. V.</given-names></name><article-title>Online chemical
modeling environment (OCHEM): web platform for data storage, model
development and publishing of chemical information</article-title>. <source>J. Comput. Aided Mol. Des.</source><year>2011</year>, <volume>25</volume>, <fpage>533</fpage>–<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1007/s10822-011-9440-2</pub-id>.<pub-id pub-id-type="pmid">21660515</pub-id></mixed-citation>
    </ref>
    <ref id="ref5">
      <mixed-citation publication-type="journal" id="cit5"><name><surname>Pires</surname><given-names>D. E. V.</given-names></name>; <name><surname>Blundell</surname><given-names>T. L.</given-names></name>; <name><surname>Ascher</surname><given-names>D. B.</given-names></name><article-title>pkCSM: predicting
small-molecule
pharmacokinetic and toxicity properties using graph-based signatures</article-title>. <source>J. Med. Chem.</source><year>2015</year>, <volume>58</volume>, <fpage>4066</fpage>–<lpage>4072</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b00104</pub-id>.<pub-id pub-id-type="pmid">25860834</pub-id></mixed-citation>
    </ref>
    <ref id="ref6">
      <mixed-citation publication-type="journal" id="cit6"><name><surname>Xiong</surname><given-names>G.</given-names></name>; <name><surname>Wu</surname><given-names>Z.</given-names></name>; <name><surname>Yi</surname><given-names>J.</given-names></name>; <name><surname>Fu</surname><given-names>L.</given-names></name>; <name><surname>Yang</surname><given-names>Z.</given-names></name>; <name><surname>Hsieh</surname><given-names>C.</given-names></name>; <name><surname>Yin</surname><given-names>M.</given-names></name>; <name><surname>Zeng</surname><given-names>X.</given-names></name>; <name><surname>Wu</surname><given-names>C.</given-names></name>; <name><surname>Lu</surname><given-names>A.</given-names></name>; <name><surname>Chen</surname><given-names>X.</given-names></name>; <name><surname>Hou</surname><given-names>T.</given-names></name>; <name><surname>Cao</surname><given-names>D.</given-names></name><article-title>ADMETlab 2.0: an integrated online platform for accurate
and comprehensive predictions of ADMET properties</article-title>. <source>Nucleic Acids Res.</source><year>2021</year>, <volume>49</volume>, <fpage>W5</fpage>–<lpage>W14</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkab255</pub-id>.<pub-id pub-id-type="pmid">33893803</pub-id></mixed-citation>
    </ref>
    <ref id="ref7">
      <mixed-citation publication-type="journal" id="cit7"><name><surname>Schyman</surname><given-names>P.</given-names></name>; <name><surname>Liu</surname><given-names>R.</given-names></name>; <name><surname>Desai</surname><given-names>V.</given-names></name>; <name><surname>Wallqvist</surname><given-names>A.</given-names></name><article-title>vNN web server for ADMET predictions</article-title>. <source>Front. Pharmacol.</source><year>2017</year>, <volume>8</volume>, <fpage>889</fpage><pub-id pub-id-type="doi">10.3389/fphar.2017.00889</pub-id>.<pub-id pub-id-type="pmid">29255418</pub-id></mixed-citation>
    </ref>
    <ref id="ref8">
      <mixed-citation publication-type="journal" id="cit8"><name><surname>Mendez</surname><given-names>D.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Chambers</surname><given-names>J.</given-names></name>; <name><surname>De Veij</surname><given-names>M.</given-names></name>; <name><surname>Félix</surname><given-names>E.</given-names></name>; <name><surname>Magariños</surname><given-names>M. P.</given-names></name>; <name><surname>Mosquera</surname><given-names>J. F.</given-names></name>; <name><surname>Mutowo</surname><given-names>P.</given-names></name>; <name><surname>Nowotka</surname><given-names>M.</given-names></name>; <name><surname>Gordillo-Marañón</surname><given-names>M.</given-names></name>; <name><surname>Hunter</surname><given-names>F.</given-names></name>; <name><surname>Junco</surname><given-names>L.</given-names></name>; <name><surname>Mugumbate</surname><given-names>G.</given-names></name>; <name><surname>Rodriguez-Lopez</surname><given-names>M.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Bosc</surname><given-names>N.</given-names></name>; <name><surname>Radoux</surname><given-names>C. J.</given-names></name>; <name><surname>Segura-Cabrera</surname><given-names>A.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Leach</surname><given-names>A. R.</given-names></name><article-title>ChEMBL:
towards
direct deposition of bioassay data</article-title>. <source>Nucleic
Acids Res.</source><year>2019</year>, <volume>47</volume>, <fpage>D930</fpage>–<lpage>D940</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1075</pub-id>.<pub-id pub-id-type="pmid">30398643</pub-id></mixed-citation>
    </ref>
    <ref id="ref9">
      <mixed-citation publication-type="journal" id="cit9"><name><surname>Wang</surname><given-names>Y.</given-names></name>; <name><surname>Bryant</surname><given-names>S. H.</given-names></name>; <name><surname>Cheng</surname><given-names>T.</given-names></name>; <name><surname>Wang</surname><given-names>J.</given-names></name>; <name><surname>Gindulyte</surname><given-names>A.</given-names></name>; <name><surname>Shoemaker</surname><given-names>B. A.</given-names></name>; <name><surname>Thiessen</surname><given-names>P. A.</given-names></name>; <name><surname>He</surname><given-names>S.</given-names></name>; <name><surname>Zhang</surname><given-names>J.</given-names></name><article-title>PubChem BioAssay:
2017 update</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>D955</fpage>–<lpage>D963</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1118</pub-id>.<pub-id pub-id-type="pmid">27899599</pub-id></mixed-citation>
    </ref>
    <ref id="ref10">
      <mixed-citation publication-type="journal" id="cit10"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Data curation
can improve the prediction
accuracy of metabolic intrinsic clearance</article-title>. <source>Mol.
Inf.</source><year>2019</year>, <volume>38</volume>, <elocation-id>e1800086</elocation-id><pub-id pub-id-type="doi">10.1002/minf.201800086</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref11">
      <mixed-citation publication-type="journal" id="cit11"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Predicting
fraction unbound in human plasma from chemical structure: improved
accuracy in the low value ranges</article-title>. <source>Mol. Pharm.</source><year>2018</year>, <volume>15</volume>, <fpage>5302</fpage>–<lpage>5311</lpage>. <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.8b00785</pub-id>.<pub-id pub-id-type="pmid">30259749</pub-id></mixed-citation>
    </ref>
    <ref id="ref12">
      <mixed-citation publication-type="journal" id="cit12"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Development
of an <italic>In Silico</italic> Prediction Model for P-glycoprotein
Efflux Potential in Brain Capillary Endothelial Cells toward the Prediction
of Brain Penetration</article-title>. <source>J. Med. Chem.</source><year>2021</year>, <volume>64</volume>, <fpage>2725</fpage>–<lpage>2738</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jmedchem.0c02011</pub-id>.<pub-id pub-id-type="pmid">33619967</pub-id></mixed-citation>
    </ref>
    <ref id="ref13">
      <mixed-citation publication-type="journal" id="cit13"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Computational
model to predict the fraction of unbound drug in the brain</article-title>. <source>J. Chem. Inf. Model.</source><year>2019</year>, <volume>59</volume>, <fpage>3251</fpage>–<lpage>3261</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jcim.9b00180</pub-id>.<pub-id pub-id-type="pmid">31260629</pub-id></mixed-citation>
    </ref>
    <ref id="ref14">
      <mixed-citation publication-type="journal" id="cit14"><name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Constructing
an in silico three-class predictor of human intestinal absorption
with Caco-2 permeability and dried-DMSO solubility</article-title>. <source>J. Pharm. Sci.</source><year>2019</year>, <volume>108</volume>, <fpage>3630</fpage>–<lpage>3639</lpage>. <pub-id pub-id-type="doi">10.1016/j.xphs.2019.07.014</pub-id>.<pub-id pub-id-type="pmid">31351866</pub-id></mixed-citation>
    </ref>
    <ref id="ref15">
      <mixed-citation publication-type="journal" id="cit15"><name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Natsume-Kitatani</surname><given-names>Y.</given-names></name>; <name><surname>Nagao</surname><given-names>C.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Development
of an in silico prediction system of human renal excretion and clearance
from chemical structure information incorporating fraction unbound
in plasma as a descriptor</article-title>. <source>Sci. Rep.</source><year>2019</year>, <volume>9</volume>, <fpage>18782</fpage><pub-id pub-id-type="doi">10.1038/s41598-019-55325-1</pub-id>.<pub-id pub-id-type="pmid">31827176</pub-id></mixed-citation>
    </ref>
    <ref id="ref16">
      <mixed-citation publication-type="journal" id="cit16"><name><surname>Kanehisa</surname><given-names>M.</given-names></name>; <name><surname>Furumichi</surname><given-names>M.</given-names></name>; <name><surname>Tanabe</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>Y.</given-names></name>; <name><surname>Morishima</surname><given-names>K.</given-names></name><article-title>KEGG: new
perspectives on genomes, pathways, diseases and drugs</article-title>. <source>Nucleic Acids Res.</source><year>2017</year>, <volume>45</volume>, <fpage>D353</fpage>–<lpage>D361</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkw1092</pub-id>.<pub-id pub-id-type="pmid">27899662</pub-id></mixed-citation>
    </ref>
    <ref id="ref17">
      <mixed-citation publication-type="journal" id="cit17"><name><surname>Wishart</surname><given-names>D. S.</given-names></name>; <name><surname>Feunang</surname><given-names>Y. D.</given-names></name>; <name><surname>Guo</surname><given-names>A. C.</given-names></name>; <name><surname>Lo</surname><given-names>E. J.</given-names></name>; <name><surname>Marcu</surname><given-names>A.</given-names></name>; <name><surname>Grant</surname><given-names>J. R.</given-names></name>; <name><surname>Sajed</surname><given-names>T.</given-names></name>; <name><surname>Johnson</surname><given-names>D.</given-names></name>; <name><surname>Li</surname><given-names>C.</given-names></name>; <name><surname>Sayeeda</surname><given-names>Z.</given-names></name>; <name><surname>Assempour</surname><given-names>N.</given-names></name>; <name><surname>Iynkkaran</surname><given-names>I.</given-names></name>; <name><surname>Liu</surname><given-names>Y.</given-names></name>; <name><surname>Maciejewski</surname><given-names>A.</given-names></name>; <name><surname>Gale</surname><given-names>N.</given-names></name>; <name><surname>Wilson</surname><given-names>A.</given-names></name>; <name><surname>Chin</surname><given-names>L.</given-names></name>; <name><surname>Cummings</surname><given-names>R.</given-names></name>; <name><surname>Le</surname><given-names>D.</given-names></name>; <name><surname>Pon</surname><given-names>A.</given-names></name>; <name><surname>Knox</surname><given-names>C.</given-names></name>; <name><surname>Wilson</surname><given-names>M.</given-names></name><article-title>DrugBank 5.0: a major update to the DrugBank database
for 2018</article-title>. <source>Nucleic Acids Res.</source><year>2018</year>, <volume>46</volume>, <fpage>D1074</fpage>–<lpage>D1082</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkx1037</pub-id>.<pub-id pub-id-type="pmid">29126136</pub-id></mixed-citation>
    </ref>
    <ref id="ref18">
      <mixed-citation publication-type="journal" id="cit18"><name><surname>Chen</surname><given-names>Y. A.</given-names></name>; <name><surname>Tripathi</surname><given-names>L. P.</given-names></name>; <name><surname>Fujiwara</surname><given-names>T.</given-names></name>; <name><surname>Kameyama</surname><given-names>T.</given-names></name>; <name><surname>Itoh</surname><given-names>M. N.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>The TargetMine data warehouse: enhancement and updates</article-title>. <source>Front. Genet.</source><year>2019</year>, <volume>10</volume>, <fpage>934</fpage><pub-id pub-id-type="doi">10.3389/fgene.2019.00934</pub-id>.<pub-id pub-id-type="pmid">31649722</pub-id></mixed-citation>
    </ref>
    <ref id="ref19">
      <mixed-citation publication-type="journal" id="cit19"><name><surname>Bienfait</surname><given-names>B.</given-names></name>; <name><surname>Ertl</surname><given-names>P.</given-names></name><article-title>JSME: a free molecule
editor in JavaScript</article-title>. <source>J. Cheminf.</source><year>2013</year>, <volume>5</volume>, <fpage>24</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-5-24</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref20">
      <mixed-citation publication-type="weblink" id="cit20"><article-title>RDKit: Open-source cheminformatics software</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.rdkit.org/">http://www.rdkit.org/</uri> (accessed
Mar 8, 2023).</mixed-citation>
    </ref>
    <ref id="ref21">
      <mixed-citation publication-type="journal" id="cit21"><name><surname>Heller</surname><given-names>S. R.</given-names></name>; <name><surname>McNaught</surname><given-names>A.</given-names></name>; <name><surname>Pletnev</surname><given-names>I.</given-names></name>; <name><surname>Stein</surname><given-names>S.</given-names></name>; <name><surname>Tchekhovskoi</surname><given-names>D.</given-names></name><article-title>InChI, the
IUPAC international chemical identifier</article-title>. <source>J.
Cheminf.</source><year>2015</year>, <volume>7</volume>, <fpage>23</fpage><pub-id pub-id-type="doi">10.1186/s13321-015-0068-4</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref22">
      <mixed-citation publication-type="journal" id="cit22"><name><surname>Weininger</surname><given-names>D.</given-names></name>; <name><surname>Weininger</surname><given-names>A.</given-names></name>; <name><surname>Weininger</surname><given-names>J. L.</given-names></name><article-title>SMILES 2. Algorithm for generation
of unique SMILES notation</article-title>. <source>J. Chem. Inf. Comput.
Sci.</source><year>1989</year>, <volume>29</volume>, <fpage>97</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1021/ci00062a008</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref23">
      <mixed-citation publication-type="journal" id="cit23"><name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Yuki</surname><given-names>H.</given-names></name>; <name><surname>Ogura</surname><given-names>K.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name><article-title>Construction of an
integrated database for hERG blocking small molecules</article-title>. <source>PLoS One</source><year>2018</year>, <volume>13</volume>, <elocation-id>e0199348</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0199348</pub-id>.<pub-id pub-id-type="pmid">29979714</pub-id></mixed-citation>
    </ref>
    <ref id="ref24">
      <mixed-citation publication-type="weblink" id="cit24"><article-title>DILI-cSEARCH</article-title>. <uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://dili-csearch.nibiohn.go.jp/en">https://dili-csearch.nibiohn.go.jp/en</uri> (accessed Mar 8, 2023).</mixed-citation>
    </ref>
    <ref id="ref25">
      <mixed-citation publication-type="journal" id="cit25"><name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>A public-private
partnership to enrich the development of in silico predictive models
for pharmacokinetic and cardiotoxic properties</article-title>. <source>Drug Discov. Today</source><year>2021</year>, <volume>26</volume>, <fpage>1275</fpage>–<lpage>1283</lpage>. <pub-id pub-id-type="doi">10.1016/j.drudis.2021.01.024</pub-id>.<pub-id pub-id-type="pmid">33516857</pub-id></mixed-citation>
    </ref>
    <ref id="ref26">
      <mixed-citation publication-type="journal" id="cit26"><name><surname>Kuroda</surname><given-names>M.</given-names></name>; <name><surname>Watanabe</surname><given-names>R.</given-names></name>; <name><surname>Esaki</surname><given-names>T.</given-names></name>; <name><surname>Kawashima</surname><given-names>H.</given-names></name>; <name><surname>Ohashi</surname><given-names>R.</given-names></name>; <name><surname>Sato</surname><given-names>T.</given-names></name>; <name><surname>Honma</surname><given-names>T.</given-names></name>; <name><surname>Komura</surname><given-names>H.</given-names></name>; <name><surname>Mizuguchi</surname><given-names>K.</given-names></name><article-title>Utilizing public and private sector
data to build better
machine learning models for the prediction of pharmacokinetic parameters</article-title>. <source>Drug Discov. Today</source><year>2022</year>, <volume>27</volume>, <fpage>103339</fpage><pub-id pub-id-type="doi">10.1016/j.drudis.2022.103339</pub-id>.<pub-id pub-id-type="pmid">35973660</pub-id></mixed-citation>
    </ref>
    <ref id="ref27">
      <mixed-citation publication-type="journal" id="cit27"><name><surname>Varma</surname><given-names>M. V. S.</given-names></name>; <name><surname>Feng</surname><given-names>B.</given-names></name>; <name><surname>Obach</surname><given-names>R. S.</given-names></name>; <name><surname>Troutman</surname><given-names>M. D.</given-names></name>; <name><surname>Chupka</surname><given-names>J.</given-names></name>; <name><surname>Miller</surname><given-names>H. R.</given-names></name>; <name><surname>El-Kattan</surname><given-names>A.</given-names></name><article-title>Physicochemical
determinants of human
renal clearance</article-title>. <source>J. Med. Chem.</source><year>2009</year>, <volume>52</volume>, <fpage>4844</fpage>–<lpage>4852</lpage>. <pub-id pub-id-type="doi">10.1021/jm900403j</pub-id>.<pub-id pub-id-type="pmid">19445515</pub-id></mixed-citation>
    </ref>
    <ref id="ref28">
      <mixed-citation publication-type="journal" id="cit28"><name><surname>Varma</surname><given-names>M. V. S.</given-names></name>; <name><surname>Obach</surname><given-names>R. S.</given-names></name>; <name><surname>Rotter</surname><given-names>C.</given-names></name>; <name><surname>Miller</surname><given-names>H. R.</given-names></name>; <name><surname>Chang</surname><given-names>G.</given-names></name>; <name><surname>Steyn</surname><given-names>S. J.</given-names></name>; <name><surname>El-Kattan</surname><given-names>A.</given-names></name>; <name><surname>Troutman</surname><given-names>M. D.</given-names></name><article-title>Physicochemical
space for optimum oral bioavailability: contribution of human intestinal
absorption and first pass elimination</article-title>. <source>J. Med.
Chem.</source><year>2010</year>, <volume>53</volume>, <fpage>1098</fpage>–<lpage>1108</lpage>. <pub-id pub-id-type="doi">10.1021/jm901371v</pub-id>.<pub-id pub-id-type="pmid">20070106</pub-id></mixed-citation>
    </ref>
    <ref id="ref29">
      <mixed-citation publication-type="journal" id="cit29"><name><surname>Ito</surname><given-names>S.</given-names></name>; <name><surname>Ando</surname><given-names>H.</given-names></name>; <name><surname>Ose</surname><given-names>A.</given-names></name>; <name><surname>Kitamura</surname><given-names>Y.</given-names></name>; <name><surname>Ando</surname><given-names>T.</given-names></name>; <name><surname>Kusuhara</surname><given-names>H.</given-names></name>; <name><surname>Sugiyama</surname><given-names>Y.</given-names></name><article-title>Relationship
between the urinary
excretion mechanisms of drugs and their physicochemical properties</article-title>. <source>J. Pharm. Sci.</source><year>2013</year>, <volume>102</volume>, <fpage>3294</fpage>–<lpage>3301</lpage>. <pub-id pub-id-type="doi">10.1002/jps.23599</pub-id>.<pub-id pub-id-type="pmid">23712676</pub-id></mixed-citation>
    </ref>
    <ref id="ref30">
      <mixed-citation publication-type="journal" id="cit30"><name><surname>Benet</surname><given-names>L. Z.</given-names></name>; <name><surname>Broccatelli</surname><given-names>F.</given-names></name>; <name><surname>Oprea</surname><given-names>T. I.</given-names></name><article-title>BDDCS applied to over 900 drugs</article-title>. <source>AAPS J.</source><year>2011</year>, <volume>13</volume>, <fpage>519</fpage>–<lpage>547</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-011-9290-9</pub-id>.<pub-id pub-id-type="pmid">21818695</pub-id></mixed-citation>
    </ref>
    <ref id="ref31">
      <mixed-citation publication-type="journal" id="cit31"><name><surname>Hosey</surname><given-names>C. M.</given-names></name>; <name><surname>Chan</surname><given-names>R.</given-names></name>; <name><surname>Benet</surname><given-names>L. Z.</given-names></name><article-title>BDDCS predictions,
self-correcting
aspects of BDDCS assignments, BDDCS assignment corrections, and classification
for more than 175 additional drugs</article-title>. <source>AAPS J.</source><year>2016</year>, <volume>18</volume>, <fpage>251</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.1208/s12248-015-9845-2</pub-id>.<pub-id pub-id-type="pmid">26589308</pub-id></mixed-citation>
    </ref>
    <ref id="ref32">
      <mixed-citation publication-type="journal" id="cit32"><name><surname>Bento</surname><given-names>A. P.</given-names></name>; <name><surname>Hersey</surname><given-names>A.</given-names></name>; <name><surname>Félix</surname><given-names>E.</given-names></name>; <name><surname>Landrum</surname><given-names>G.</given-names></name>; <name><surname>Gaulton</surname><given-names>A.</given-names></name>; <name><surname>Atkinson</surname><given-names>F.</given-names></name>; <name><surname>Bellis</surname><given-names>L. J.</given-names></name>; <name><surname>De Veij</surname><given-names>M.</given-names></name>; <name><surname>Leach</surname><given-names>A. R.</given-names></name><article-title>An open
source chemical structure curation pipeline using RDKit</article-title>. <source>J. Cheminf.</source><year>2020</year>, <volume>12</volume>, <fpage>51</fpage><pub-id pub-id-type="doi">10.1186/s13321-020-00456-1</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref33">
      <mixed-citation publication-type="journal" id="cit33"><name><surname>O’Boyle</surname><given-names>N. M.</given-names></name>; <name><surname>Banck</surname><given-names>M.</given-names></name>; <name><surname>James</surname><given-names>C. A.</given-names></name>; <name><surname>Morley</surname><given-names>C.</given-names></name>; <name><surname>Vandermeersch</surname><given-names>T.</given-names></name>; <name><surname>Hutchison</surname><given-names>G. R.</given-names></name><article-title>Open Babel:
an open chemical toolbox</article-title>. <source>J. Cheminf.</source><year>2011</year>, <volume>3</volume>, <fpage>33</fpage><pub-id pub-id-type="doi">10.1186/1758-2946-3-33</pub-id>.</mixed-citation>
    </ref>
    <ref id="ref34">
      <mixed-citation publication-type="journal" id="cit34"><name><surname>Yamazoe</surname><given-names>Y.</given-names></name>; <name><surname>Ito</surname><given-names>K.</given-names></name>; <name><surname>Yamamura</surname><given-names>Y.</given-names></name>; <name><surname>Iwama</surname><given-names>R.</given-names></name>; <name><surname>Yoshinari</surname><given-names>K.</given-names></name><article-title>Prediction
of regioselectivity and preferred order of metabolisms on CYP1A2-mediated
reactions. Part 1. Focusing on polycyclic arenes and the related chemicals</article-title>. <source>Drug Metab. Pharmacokinet.</source><year>2016</year>, <volume>31</volume>, <fpage>363</fpage>–<lpage>384</lpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2016.07.005</pub-id>.<pub-id pub-id-type="pmid">27665699</pub-id></mixed-citation>
    </ref>
    <ref id="ref35">
      <mixed-citation publication-type="journal" id="cit35"><name><surname>Yamazoe</surname><given-names>Y.</given-names></name>; <name><surname>Goto</surname><given-names>T.</given-names></name>; <name><surname>Tohkin</surname><given-names>M.</given-names></name><article-title>Reconstitution of CYP3A4
active site
through assembly of ligand interactions as a grid-template: solving
the modes of the metabolism and inhibition</article-title>. <source>Drug Metab. Pharmacokinet.</source><year>2019</year>, <volume>34</volume>, <fpage>113</fpage>–<lpage>125</lpage>. <pub-id pub-id-type="doi">10.1016/j.dmpk.2018.10.001</pub-id>.<pub-id pub-id-type="pmid">30639283</pub-id></mixed-citation>
    </ref>
  </ref-list>
</back>
